Advertisement

Bone (Orthopedic Pathology)

  • A. Kevin Raymond
Chapter
  • 598 Downloads

Abstract

The integration of clinical, radiographic and pathology-based information has long been intrinsic to practice of Orthopaedic Oncology, making it paradigm of multidisciplinary medicine. Extension of this multifactorial approach can lead to better understanding of heterogeneous group of entities. Historically, pathologists have approached the study of bone tumors from imaging to gross to histological findings. However, a reversal of this norm emphasizing a detailed understanding of the histopathology and growth parameters of each entity can allow a better understanding of the macroscopic / gross appearance of the orthopaedic tumors which in turn leads to a better appreciation of the imaging features. The chapter emphasizes those tumors most unique to bone: cartilage, osseous, small cell, fibrous, vascular, notochord, adamantinoma and giant cell lesions.

Keywords

Bone tumors Orthopedic tumors Cartilage neoplasia Osseous neoplasia Small cell neoplasia Fibrous neoplasia Small cell neoplasia Notochord neoplasia Adamantinoma Giant cell lesions 

References

  1. 1.
    Czerniak B. Dorfman and Czerniak’s Bone Tumors. 2nd ed. Philadelphia: Saunders an imprint of Elsevier; 2016.Google Scholar
  2. 2.
    Raymond AK, Lazar AJ. Orthopedic Oncologic Surgical Specimen Management and Surgical Pathology. In: Lin PP, Patel S, editors. Bone Sarcoma. New York: Springer; 2013. p. 43–75.Google Scholar
  3. 3.
    Adler C-P. Bone diseases. Macroscopic, histological, and radiological diagnosis of structural changes in the skeleton. Berlin: Springer; 2000.Google Scholar
  4. 4.
    Bovée VMG, editor. Bone tumor pathology. Surgical pathology clinics. Clinics Review Articles. 2017;10(3):513–764.Google Scholar
  5. 5.
    Bullough PG. Atlas of orthopedic pathology: with clinical and radiologic correlations. Philadelphia: Lippincott Williams & Wilkins; 1992.Google Scholar
  6. 6.
    Dahlin DC. Bone tumors: general aspects and data on 6221 cases. 3rd ed. Springfield: Charles C Thomas; 1978.Google Scholar
  7. 7.
    Campanacci M, Bertoni F, Bacchini P. Bone and soft tissue tumors. New York: Springer-Verlag; 1990.Google Scholar
  8. 8.
    Fechner RE, Mills SE. AFIP Atlas of Tumor Pathology. Series 3. Washington, DC: American Registry of Pathology; 1993.Google Scholar
  9. 9.
    Fletcher CDM, Unni KK, Mertens F. In: Mertens F, editor. WHO classification of tumours of soft tissue and bone. 4th ed. Geneva: WHO Press; 2002.Google Scholar
  10. 10.
    Fletcher CDM, Bridge JA, Hogerndoorn PCW. In: Mertens F, editor. WHO classification of tumours of soft tissue and bone. 4th ed. Geneva: WHO Press; 2013.Google Scholar
  11. 11.
    Folpe AL, Inwards CY. Bone and soft tissue pathology. Foundations in diagnostic pathology. Philadelphia: Saunders Elsevier; 2010.Google Scholar
  12. 12.
    Huvos AG. Bone tumors: diagnosis, treatment, prognosis. 2nd ed. Philadelphia: W.B. Saunders; 1990.Google Scholar
  13. 13.
    Jaffe HL, Selin G. Tumors of bones and joints. Bull N Y Acad Med. 1951;27(3):165–74. PMID: 14812254.PubMedPubMedCentralGoogle Scholar
  14. 14.
    Jaffe HL. Tumors and tumorous conditions of the bones and joints. Philadelphia: Lea & Febiger; 1972.Google Scholar
  15. 15.
    Klein MJ, Bonar SF, Freemont T, Vinh TN, Lopez-Ben R, Siegel HJ, Siegal GP. Atlas of nontumor pathology. Non-neoplastic diseases of bones and joints. Washington, DC: American Registry of Pathology; 2011.Google Scholar
  16. 16.
    Mirra JM, Picci P, Gold RH. Bone tumors. Clinical, radiologic, and pathologic correlations. Philadelphia: Lea & Febiger; 1998.Google Scholar
  17. 17.
    Nielsen GP, Rosenberg AE. Diagnostic pathology: bone. Philadelphia: Elsevier; 2017.Google Scholar
  18. 18.
    Spjut HJ, Fechner RE, Ackerman LV. Tumors of bone and cartilage. In: Hartmann WH, editor. Atlas of tumor pathology, series 2, fascicle 5, supplement. Washington, DC: Armed Forces Institute of Pathology; 1981.Google Scholar
  19. 19.
    Unni KK, Inwards CY, Bridge JA, Kindblom L-G, Wold LE. Tumors of the bones and joints, AFIP atlas of tumor pathology. Series 4. Washington, DC: American Registry of Pathology; 2005.Google Scholar
  20. 20.
    Unni KK, Inwards CY. Dahlin’s bone tumors. General aspects and data on 10,165 cases. 6th ed. Philadelphia: Lippincott, Williams, and Wilkins; 2010.Google Scholar
  21. 21.
    Wold LE, Adler C-P, Sim FH, Unni KK. Atlas of orthopedic pathology. 2nd ed. Philadelphia: Saunders-Elsevier; 2003.Google Scholar
  22. 22.
    Garcia RA, Inwards CY, Unni KK. Benign bone tumors—recent developments. Semin Diagn Pathol. 2011;28:73–85. PMID: 21675379.PubMedGoogle Scholar
  23. 23.
    Bovée JV, Hogendoorn PC, Wunder JS, et al. Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat Rev Cancer. 2010;10:481–8.PubMedGoogle Scholar
  24. 24.
    Hameetman L, Bovée JV, Taminiau AH, et al. Multiple osteochondromas: clinicopathological and genetic spectrum and suggestions for clinical management. Hered Cancer Clin Pract. 2004;2:161–73.PubMedPubMedCentralGoogle Scholar
  25. 25.
    Hameetman L, Szuhai K, Yavas A, et al. The role of EXT1 in nonhereditary osteochondroma: identification of homozygous deletions. J Natl Cancer Inst. 2007;99:396–406.PubMedGoogle Scholar
  26. 26.
    Romeo S, Hogendoorn PCW, Dei Tos AP. Benign cartilaginous tumor of bone. From morphology to somatic and germ-line genetics. Adv Anat Pathol. 2009;16:307–15.PubMedGoogle Scholar
  27. 27.
    Unni KK, Inwards CY, editors. Dahlin’s bone tumors: general aspects and data on 10,165 cases. 6th ed. Philadelphia: Lippincott Williams & Wilkins Publishers; 2010.Google Scholar
  28. 28.
    Bell WC, Klein MJ, Pitt MJ, et al. Molecular pathology of chondroid neoplasms: part 1, benign lesions. Skeletal Radiol. 2006;35:805–13.PubMedGoogle Scholar
  29. 29.
    Bovée JV, van den Broek LJ, Cleton-Jansen AM, et al. Up-regulation of PTHrP and Bcl-2 expression characterizes the progression of osteochondroma towards peripheral chondrosarcoma and is a late event in central chondrosarcoma. Lab Investig. 2000;80:1925–34.PubMedGoogle Scholar
  30. 30.
    Fletcher CDM, Bridge JA, Hogendoorn PCW, Mertens F, Unni KK, Mertens F, editors. WHO classification of tumors of soft tissue and bone. Lyon: IARC Press; 2013.Google Scholar
  31. 31.
    Wicklund CL, Pauli RM, Johnston D, Hecht JT. Natural history study of hereditary multiple exostoses. Am J Med Genet. 1995;55(1):43–6.PubMedGoogle Scholar
  32. 32.
    Wuyts W, Schmale GA, Chansky HA, Raskind WH. Hereditary multiple osteochondromas. In: Pagon RA, Adam MP, Ardinger HH, Wallace SE, Amemiya A, Bean LJH, Bird TD, Fong CT, Mefford HC, Smith RJH, Stephens K, editors. Source GeneReviews® [Internet]. Seattle: University of Washington, Seattle; 1993–2016; 2000. Aug 03 [updated 2013 Nov 21].Google Scholar
  33. 33.
    Schmale GA, Conrad EU 3rd, Raskind WH. The natural history of hereditary multiple exostoses. J Bone Joint Surg Am. 1994;76(7):986–92.PubMedGoogle Scholar
  34. 34.
    Choi BB, Jee WH, Sunwoo HJ, Cho JH, Kim JY, Chun KA, Hong SJ, Chung HW, Sung MS, Lee YS, Chung YG. MR differentiation of low-grade chondrosarcoma from enchondroma. Clin Imaging. 2013;37(3):542–7.PubMedGoogle Scholar
  35. 35.
    Fletcher CDM, Unni KK, Mertens F, editors. Pathology and genetics: tumours of soft tissue and bone. Lyon: IARC Press; 2002.Google Scholar
  36. 36.
    Tallini G, Dorfman H, Brys P, Dal Cin P, de Wever I, Fletcher CD, Jonson K, Mandahl N, Mertens F, Miltelman F, Rosai J, Rydholm A, Samson I, Sciot R, van den Berghe H, Vanni R, Willén H. Correlation between clinicopathological features and karyotype in 100 cartilaginous and chordoid tumours. A report from the Chromosomes and Morphology (CHAMP) Collaborative Study Group. J Pathol. 2002;196:194–203.PubMedGoogle Scholar
  37. 37.
    Lichtenstein L, Hall JE. Periosteal chondroma; a distinctive benign cartilage tumor. J Bone Joint Surg Am. 1952;24 A(3):691–7.PubMedGoogle Scholar
  38. 38.
    Rabarin F, Laulan J, Saint Cast Y, Césari B, Fouque PA, Raimbeau G. Focal periosteal chondroma of the hand: a review of 24 cases. Orthop Traumatol Surg Res. 2014;100(6):617–20.PubMedGoogle Scholar
  39. 39.
    Boriani S, Bacchini P, Bertoni F, Campanacci M. Periosteal chondroma. A review of twenty cases. J Bone Joint Surg Am. 1983;65(2):205–12.PubMedGoogle Scholar
  40. 40.
    Nojima T, Unni KK, McLeod RA, Pritchard DJ. Periosteal chondroma and periosteal chondrosarcoma. Am J Surg Pathol. 1985;9(9):666–77.PubMedGoogle Scholar
  41. 41.
    Bauer TW, Dorfman HD, Latham JT Jr. Periosteal chondroma. A clinicopathologic study of 23 cases. Am J Surg Pathol. 1982;6(7):631–7.PubMedGoogle Scholar
  42. 42.
    deSantos LA, Spjut HJ. Periosteal chondroma: a radiographic spectrum. Skelet Radiol. 1981;6(1):15–20.Google Scholar
  43. 43.
    Nishio J, Arashiro Y, Mori S, Iwasaki H, Naito M. Periosteal chondroma of the distal tibia: computed tomography and magnetic resonance imaging characteristics and correlation with histological findings. Mol Clin Oncol. 2015;3(3):677–81. Epub 2015 Jan 22.PubMedPubMedCentralGoogle Scholar
  44. 44.
    Varma DG, Kumar R, Carrasco CH, Guo SQ, Richli WR. MR imaging of periosteal chondroma. J Comput Assist Tomogr. 1991;15(6):1008–10.PubMedGoogle Scholar
  45. 45.
    Fletcher CDM, Bridge JA, Hogerndoorn PCW, Mertens F. In: Mertens F, editor. WHO classification of tumours of soft tissue and bone. 4th ed. Geneva: WHO Press; 2013.Google Scholar
  46. 46.
    Pansuriya TC, Kroon HM, Bovée JV. Enchondromatosis: insights on the different subtypes. Int J Clin Exp Pathol. 2010;3(6):557–69. Review.PubMedPubMedCentralGoogle Scholar
  47. 47.
    Liu J, Hudkins PG, Swee RG, Unni KK. Bone sarcomas associated with Ollier’s disease. Cancer. 1987;59(7):1376–85.PubMedGoogle Scholar
  48. 48.
    Pansuriya TC, van Eijk R, d’Adamo P, van Ruler MA, Kuijjer ML, Oosting J, Cleton-Jansen AM, van Oosterwijk JG, Verbeke SL, Meijer D, van Wezel T, Nord KH, Sangiorgi L, Toker B, Liegl-Atzwanger B, San-Julian M, Sciot R, Limaye N, Kindblom LG, Daugaard S, Godfraind C, Boon LM, Vikkula M, Kurek KC, Szuhai K, French PJ, Bovée JV. Somatic mosaic IDH1 and IDH2 mutations are associated with enchondroma and spindle cell hemangioma in Ollier disease and Maffucci syndrome. Nat Genet. 2011;43(12):1256–61.PubMedPubMedCentralGoogle Scholar
  49. 49.
    Amary MF, Damato S, Halai D, Eskandarpour M, Berisha F, Bonar F, McCarthy S, Fantin VR, Straley KS, Lobo S, Aston W, Green CL, Gale RE, Tirabosco R, Futreal A, Campbell P, Presneau N, Flanagan AM. Ollier disease and Maffucci syndrome are caused by somatic mosaic mutations of IDH1 and IDH2. Nat Genet. 2011;43(12):1262–5.  https://doi.org/10.1038/ng.994.CrossRefPubMedGoogle Scholar
  50. 50.
    Fanburg JC, Meis-Kindblom JM, Rosenberg AE. Multiple enchondromas associated with spindle-cell hemangioendotheliomas. An overlooked variant of Maffucci’s syndrome. Am J Surg Pathol. 1995;19(9):1029–38.PubMedGoogle Scholar
  51. 51.
    Pellegrini AE, Drake RD, Qualman SJ. Spindle cell hemangioendothelioma: a neoplasm associated with Maffucci’s syndrome. J Cutan Pathol. 1995;22(2):173–6.PubMedGoogle Scholar
  52. 52.
    Schaison F, Anract P, Coste F, Pinieux G, Forest M, Tomeno B. [Chondrosarcoma secondary to multiple cartilage diseases. Study of 29 clinical cases and review of the literature].Rev Chir Orthop Reparatrice Appar Mot. 1999;85(8):834–45.PubMedGoogle Scholar
  53. 53.
    Schwartz HS, Zimmerman NB, Simon MA, Wroble RR, Millar EA, Bonfiglio M. The malignant potential of enchondromatosis. J Bone Joint Surg Am. 1987;69(2):269–74.PubMedGoogle Scholar
  54. 54.
    Verdegaal SH, Bovée JV, Pansuriya TC, Grimer RJ, Ozger H, Jutte PC, San Julian M, Biau DJ, van der Geest IC, Leithner A, Streitbürger A, Klenke FM, Gouin FG, Campanacci DA, Marec-Berard P, Hogendoorn PC, Brand R, Taminiau AH. Incidence, predictive factors, and prognosis of chondrosarcoma in patients with Ollier disease and Maffucci syndrome: an international multicenter study of 161 patients. Oncologist. 2011;16(12):1771–9.PubMedPubMedCentralGoogle Scholar
  55. 55.
    Lichtenstein L, Jaffe HL. Chondrosarcoma of bone. Am J Pathol. 1943;19(4):553–89.PubMedPubMedCentralGoogle Scholar
  56. 56.
    Pritchard DJ, Lunke RJ, Taylor WF, Dahlin DC, Medley BE. Chondrosarcoma: a clinicopathologic and statistical analysis. Cancer. 1980;45(1):149–57.PubMedGoogle Scholar
  57. 57.
    Dahlin DC, Henderson ED. Chondrosarcoma, a surgical and pathological problem; review of 212 cases. J Bone Joint Surg Am. 1956;38-A(5):1025–38.PubMedGoogle Scholar
  58. 58.
    Evans HL, Ayala AG, Romsdahl MM. Prognostic factors in chondrosarcoma of bone. A clinicopathologic analysis with emphasis on histologic grading. Cancer. 1977;40(2):818–31.PubMedGoogle Scholar
  59. 59.
    Eefting D, Scharage YM, Geirnaerdt MJ, Le Cessie S, Taminiau AH, Bovée JV, Hogendoorn PC, EroBoNeT consortium. Assessment of interobserver variability and histologic parameters to improve reliability in classification and grading of central cartilaginous tumors. Am J Surg Pathol. 2009;33(1):50–7.PubMedGoogle Scholar
  60. 60.
    Wang W-L, Hilliard NJ, Deavers MT, Lewis VO, Raymond AK. Chondrosarcomas: skip metastasis. Lab Invest. 2009;89(Suppl 1):25A.Google Scholar
  61. 61.
    Björnsson J, McLeod RA, Unni KK, Ilstrup DM, Pritchard DJ. Primary chondrosarcoma of long bones and limb girdles. Cancer. 1998;83(10):2105–19.PubMedGoogle Scholar
  62. 62.
    Henderson ED, Dahlin DC. Chondrosarcoma of bone—a study of two hundred and eighty-eight cases. J Bone Joint Surg Am. 1963;45:1450–8. No abstract available.PubMedGoogle Scholar
  63. 63.
    Lichtenstein L. Tumors of periosteal origin. Cancer. 1955;8:1060–9.PubMedGoogle Scholar
  64. 64.
    Bertoni F, Boriani S, Laus M, Campanacci M. Periosteal chondrosarcoma and periosteal osteosarcoma: two distinct entities. J Bone Joint Surg Br. 1982;64:370–6.PubMedGoogle Scholar
  65. 65.
    Chaabane S, Bouaziz MC, Drissi C, Ladeeb MF. Periosteal chondrosarcoma. AJR Am J Roentgenol. 2009;192:1–6.Google Scholar
  66. 66.
    Matsumoto K, Hukuda S, Ishizawa M, Saruhashi Y, Okabe H, Asano Y. Parosteal (juxtacortical) chondrosarcoma of the humerus associated with regional lymph node metastasis. A case report. Clin Orthop Relat Res. 1993;290:168–73.Google Scholar
  67. 67.
    Papagelopoulos PJ, Galanis EC, Mavrogenis AF, Savvidou OD, Bond JR, Unni KK, Sim FH. Survivorship analysis in patients with periosteal chondrosarcoma. Clin Orthop Relat Res. 2006;448:199–207.PubMedGoogle Scholar
  68. 68.
    Schajowicz F. Juxtacortical chondrosarcoma. J Bone Joint Surg. 1977;59B:473–80.Google Scholar
  69. 69.
    Kumta SM, Griffith JF, Chow LT, Leung PC. Primary juxtacortical chondrosarcoma dedifferentiating after 20 years. Skeletal Radiol. 1998;27:569–73.PubMedGoogle Scholar
  70. 70.
    Vanel D, De Paolis M, Monti C, Mercuri M, Picci P. Radiological features of 24 periosteal chondrosarcomas. Skeletal Radiol. 2001;30:208–12.PubMedGoogle Scholar
  71. 71.
    Ahmed AR, Tan TS, Unni KK, Collins MS, Wenger DE, Sim FH. Secondary chondrosarcoma in osteochondroma: report of 107 patients. Clin Orthop Relat Res. 2003;411:193–206.Google Scholar
  72. 72.
    Garrison RC, Unni KK, McLeod RA, Pritchard DJ, Dahlin DC. Chondrosarcoma arising in osteochondroma. Cancer. 1982;49(9):1890–7.PubMedGoogle Scholar
  73. 73.
    Lichtenstein L, Bernstein D. Unusual benign and malignant chondroid tumors of bone. Cancer. 1959;12:1142–57.Google Scholar
  74. 74.
    Bertoni F, Picci P, Bacchini P. Mesenchymal chondrosarcoma of bone and soft tissues. Cancer. 1983;52:533–41. http://www.ncbi.nlm.nih.gov/pubmed/6861090 PubMedGoogle Scholar
  75. 75.
    Cesari M, Bertoni F, Bacchini P, et al. Mesenchymal chondrosarcoma. An analysis of patients treated at single institution. Tumori. 2007;93:423–7. http://www.ncbi.nlm.nih.gov/pubmed/18038872 PubMedGoogle Scholar
  76. 76.
    Huvos AG, Rosen G, Dabska M, et al. Mesenchymal chondrosarcoma: a clinicopathologic analysis of 35 patients with emphasis on treatment. Cancer. 1983;51:1230–7.PubMedGoogle Scholar
  77. 77.
    Xu J, Li D, Lu X, Tang S, Guo W. Mesenchymal chondrosarcoma of bone and soft tissue: a systematic review of 107 patients in the past 20 years. PLoS One. 2015;10(4):e0122216.PubMedPubMedCentralGoogle Scholar
  78. 78.
    Nakashima Y, Unni KK, Shives TC, et al. Mesenchymal chondrosarcoma of bone and soft tissue: a review of 111 cases. Cancer. 1986;57:2444–53.PubMedGoogle Scholar
  79. 79.
    Swanson PE, Lillemoe TJ, Manivel JC, et al. Mesenchymal chondrosarcoma: an immunohistochemical study. Arch Pathol Lab Med. 1990;114:943–8.PubMedGoogle Scholar
  80. 80.
    Wehrli BM, Huang W, DeCrombrugghe B, Ayala AG, Czerniak B. Sox9, a master regulator of chondrogenesis, distinguishes mesenchymal chondrosarcoma from other small blue round cell tumors. Hum Pathol. 2003;34:263–9.PubMedGoogle Scholar
  81. 81.
    Lee AF, Hayes MM, Lebrun D, et al. FLI-1 distinguishes Ewing sarcoma from small cell osteosarcoma and mesenchymal chondrosarcoma. Appl Immunohistochem Mol Morphol. 2011;19:233–8.PubMedGoogle Scholar
  82. 82.
    Wang L, Motoi T, Khanin R, Olshen A, Mertens F, Bridge J, Dal Cin P, Antonescu CR, Singer S, Hameed M, Bovee JV, Hogendoorn PC, Socci N, Ladanyi M. Identification of a novel, recurrent HEY1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data. Genes Chromosomes Cancer. 2012;51(2):127–39.  https://doi.org/10.1002/gcc.20937.CrossRefPubMedGoogle Scholar
  83. 83.
    Damato S, Alorjiani M, Bonar F, et al. IDH1 mutations are not found in cartilaginous tumours other than central and periosteal chondrosarcomas and enchondromas. Histopathology. 2012;60:363–5.PubMedGoogle Scholar
  84. 84.
    Frassica FJ, Unni KK, Beabout JW, Sim FH. Dedifferentiated chondrosarcoma: a report of the clinicopathological features and treatment of seventy-eight cases. J Bone Joint Surg. 1986;68A:1197–205.Google Scholar
  85. 85.
    Mirra JM, Marcove RC. Fibrosarcomatous dedifferentiation of primary and secondary chondrosarcoma. J Bone Joint Surg. 1974;56A:285–96.Google Scholar
  86. 86.
    Sanerkin NG, Woods CG. Fibrosarcomata and malignant fibrous histiocytomata arising in relation to enchondromata. J Bone Joint Surg. 1979;61B:366–72.Google Scholar
  87. 87.
    Dahlin DC, Beabout JW. Differentiation of low-grade chondrosarcomas. Cancer. 1971;28:461–6.PubMedGoogle Scholar
  88. 88.
    Staals EL, Bacchini P, Bertoni F. Dedifferentiated central chondrosarcoma. Cancer. 2006;106(12):2682–91.PubMedGoogle Scholar
  89. 89.
    Munk PL, Connell DG, Quenville NF. Dedifferentiated chondrosarcoma of bone with leiomyosarcomatous mesenchymal component: a case report. Can Assoc Radiol J. 1988;39:218–20.PubMedGoogle Scholar
  90. 90.
    Niezabitowski A, Edel G, Roessner A, Grundmann E, Timm C, Wuisman P. Rhabdomyosarcomatous component in dedifferentiated chondrosarcoma. Pathol Res Pract. 1987;182:275–82.PubMedGoogle Scholar
  91. 91.
    Okada K, Hasegawa T, Tateishi U, Endo M, Itoi E. Dedifferentiated chondrosarcoma with telangiectatic osteosarcoma-like features. J Clin Pathol. 2006;59:1200–2.PubMedPubMedCentralGoogle Scholar
  92. 92.
    Estrada EG, Ayala AG, Lewis V, Czerniak B. Dedifferentiated chondrosarcoma with a noncartilaginous component mimicking a conventional giant cell tumor of bone. Ann Diagn Pathol. 2002;6:159–63.PubMedGoogle Scholar
  93. 93.
    Bierry G, Feydy A, Larousserie F, Pluot E, Guerini H, Campagna R, Dufau-Andreu C, Anract P, Babinet A, Dietemann JL, Chevrot A, Drapé JL. Dedifferentiated chondrosarcoma: radiologic-pathologic correlation. J Radiol. 2010;91(3 Pt 1):271–9.PubMedGoogle Scholar
  94. 94.
    Unni KK, Dahlin DC, Beabout JW, Sim FH. Chondrosarcoma: clear-cell variant—a report of 16 cases. J Bone Joint Surg. 1976;58A:676–83.Google Scholar
  95. 95.
    Bjornsson J, Unni KK, Dahlin DC, Beabout JW, Sim FH. Clear cell chondrosarcoma of bone: observations in 47 cases. Am J Surg Pathol. 1984;8:223–30.PubMedGoogle Scholar
  96. 96.
    Campanacci M, Bertoni F, Laus M. Clear cell chondrosarcoma. Ital J Orthop Traumatol. 1980;6(3):365–72.PubMedGoogle Scholar
  97. 97.
    van Oosterwijk JG, Meijer D, van Ruler MA, van den Akker BE, Oosting J, Krenács T, Picci P, Flanagan AM, Liegl-Atzwanger B, Leithner A, Athanasou N, Daugaard S, Hogendoorn PC, Bovée JV. Screening for potential targets for therapy in mesenchymal, clear cell, and dedifferentiated chondrosarcoma reveals Bcl-2 family members and TGFβ as potential targets. Am J Pathol. 2013;182(4):1347–56.PubMedGoogle Scholar
  98. 98.
    Wang LT, Liu TC. Clear cell chondrosarcoma of bone: a report of three cases with immunohistochemical and affinity histochemical observations. Pathol Res Pract. 1993;189:411–5.PubMedGoogle Scholar
  99. 99.
    Collins MS, Koyama T, Swee RG, Inward CY. Clear cell chondrosarcoma: radiographic, computed tomographic, and magnetic resonance findings in 34 patients with pathologic correlation. Skelet Radiol. 2003;32:687–94.Google Scholar
  100. 100.
    Codman EA. Epiphyseal chondromatous giant cell tumors of the upper end of the humerus. Surg Gynecol Obstet. 1931;52:543–8.Google Scholar
  101. 101.
    Dahlin DC, Ivins JC. Benign chondroblastoma: a study of 125 cases. Cancer. 1972;30:401–13.PubMedGoogle Scholar
  102. 102.
    Jaffe HL, Lichtenstein L. Benign chondroblastoma of bone: a reinterpretation of the so-called calcifying or chondromatous giant cell tumor. Am J Pathol. 1942;18(6):969–91.PubMedPubMedCentralGoogle Scholar
  103. 103.
    Lin PP, Thenappan A, Deavers MT, Lewis VO, Yasko AW. Treatment and prognosis of chondroblastoma. Clin Orthop Relat Res. 2005;438:103–9.PubMedGoogle Scholar
  104. 104.
    Green P, Whittaker RP. Benign chondroblastoma: case report with pulmonary metastasis. J Bone Joint Surg. 1975;57A:418–20.Google Scholar
  105. 105.
    Mirra JM, Ulich TR, Eckardt JJ, Bhuta S. “Aggressive” chondroblastoma: light and ultramicroscropic findings after en bloc resection. Clin Orthop. 1983;178:276–84.Google Scholar
  106. 106.
    Dancer JY, Henry SP, Bondaruk J, Lee S, Ayala AG, de Crombrugghe B, Czerniak B. Expression of master regulatory genes controlling skeletal development in benign cartilage and bone forming tumors. Hum Pathol. 2010;41:1788–93.PubMedPubMedCentralGoogle Scholar
  107. 107.
    Swarts SJ, Neff JR, Johansson SL, Nelson M, Bridge JA. Significance of abnormalities of chromosomes 5 and 8 in chondroblastoma. Clin Orthop Relat Res. 1998;349:189–93.Google Scholar
  108. 108.
    Brecher ME, Simon MA. Chondroblastoma: an immunohistochemical study. Hum Pathol. 1988;19:1043–7.PubMedGoogle Scholar
  109. 109.
    Konishi E, Nakashima Y, Iwasa Y, Nakao R, Yanagisawa A. Immunohistochemical analysis for Sox9 reveals the cartilaginous character of chondroblastoma and chondromyxoid fibroma of the bone. Hum Pathol. 2010;41:208–13.PubMedGoogle Scholar
  110. 110.
    Jaffe HL, Lichtenstein L. Chondromyxoid fibroma of bone: distinctive benign tumor likely to be mistaken especially for chondrosarcoma. Arch Pathol. 1948;45:541–51.Google Scholar
  111. 111.
    Dahlin DC. Chondromyxoid fibroma of bone, with emphasis on its morphological relationship to benign chondroblastoma. Cancer. 1956;9:195–203.PubMedGoogle Scholar
  112. 112.
    Kyriakos M. Soft tissue implantation of chondromyxoid fibroma. Am J Surg Pathol. 1979;3:363–72.PubMedGoogle Scholar
  113. 113.
    Rahimi A, Beabout JW, Ivins JC, Dahlin DC. Chondromyxoid fibroma: a clinicopathologic study of 76 cases. Cancer. 1972;30:726–36.PubMedGoogle Scholar
  114. 114.
    Söder S, Inwards C, Müller S, Kirchner T, Aigner T. Cell biology and matrix biochemistry of chondromyxoid fibroma. Am J Clin Pathol. 2001;116:271–7.PubMedGoogle Scholar
  115. 115.
    Wu CT, Inwards CY, O’Laughlin S, Bock MG, Geaubout JM, Unni KK. Chondromyxoid fibroma of bone: a clinicopathologic review of 278 cases. Hum Pathol. 1998;29:438–46.PubMedGoogle Scholar
  116. 116.
    Sim FH, Dahlin CD, Beabout JW. Osteoid-osteoma: diagnostic problems. J Bone Joint Surg Am. 1975;57(2):154–9.PubMedGoogle Scholar
  117. 117.
    Akhlaghpoor S, Ahari AA, Shabestari AA, Alinaghizadeh MR. Radiofrequency ablation of osteoid osteoma in atypical locations: a case series. Clin Orthop Relat Res. 2010;468:1963–70.PubMedPubMedCentralGoogle Scholar
  118. 118.
    Baruffi MR, Volpon JB, Neto JB, Casartelli C. Osteoid osteomas with chromosome alterations involving 22q. Cancer Genet Cytogenet. 2001;124:127–31.PubMedGoogle Scholar
  119. 119.
    Mylona S, Patsoura S, Galani P, Karapostolakis G, Pomoni A, Thanos L. Osteoid osteomas in common and technically challenging locations treated with computed tomography- tomography-guided percutaneous radiofrequency ablation. Skelet Radiol. 2010;39:443–9.Google Scholar
  120. 120.
    Rosenthal DI. Radiofrequency treatment. Orthop Clin North Am. 2006;37:475–84.PubMedGoogle Scholar
  121. 121.
    Hasegawa T, Hirose T, Sakamoto R, Seki K, Ikata T, Hizawa K. Mechanism of pain in osteoid osteomas: an immunohistochemical study. Histopathology. 1993;22:487–91.PubMedGoogle Scholar
  122. 122.
    Mungo DV, Zhang X, O’Keefe RJ, Rosier RN, Puzas JE, Schwarz EM. COX-1 and COX-2 expression in osteoid osteomas. J Orthop Res. 2002;20:159–62.PubMedGoogle Scholar
  123. 123.
    Cantwell CP, Obyrne J, Eustace S. Current trends in treatment of osteoid osteoma with an emphasis on radiofrequency ablation. Eur Radiol. 2004;14:607–17.PubMedGoogle Scholar
  124. 124.
    Dahlin DC. Johnson EW Jr Giant osteoid osteoma. J Bone Joint Surg Am. 1954;36-A(3):559–72.PubMedGoogle Scholar
  125. 125.
    Jaffe H. Benign osteoblastoma. Bull Hosp Joint Dis. 1956;17(2):141–51.Google Scholar
  126. 126.
    Lichtenstein L. Benign osteoblastoma: a category of osteoid-and bone-forming tumors other than classical osteoid osteoma, which may be mistaken for giant-cell tumor or osteogenic sarcoma. Cancer. 1956;9(5):1044–52.PubMedGoogle Scholar
  127. 127.
    Bettelli G, Tigani D, Picci P. Recurring osteoblastoma initially presenting as a typical osteoid osteoma: report of two cases. Skelet Radiol. 1991;20:1–4.Google Scholar
  128. 128.
    Bruneau M, Polivka M, Cornelius JF, George B. Progression of an osteoid osteoma to an osteoblastoma. Case report. J Neurosurg Spine. 2005;3:238–41.PubMedGoogle Scholar
  129. 129.
    Chotel F, Franck F, Solla F, Dijoud F, Kohler R, Berard J, Abelin Genevois K. Osteoid osteoma transformation into osteoblastoma: fact or fiction? Orthop Traumatol Surg Res. 2012;98(6):S98–S104.PubMedGoogle Scholar
  130. 130.
    Bertoni F, Unni KK, McLeod RA, Dahlin DC. Osteosarcoma resembling osteoblastoma. Cancer. 1985;55(2):416–26.PubMedGoogle Scholar
  131. 131.
    Lucas DR, Unni KK, McLeod RA, O’Conner MI, Sim FH. Osteoblastoma: clinicopathologic study of 306 cases. Hum Pathol. 1994;25:117–34.PubMedGoogle Scholar
  132. 132.
    Lucas DR. Osteoblastoma. Arch Pathol Lab Med. 2010;134:1460–6.PubMedGoogle Scholar
  133. 133.
    Mirra JM, Kendrick RA, Kendrick RE. Pseudomalignant osteoblastoma versus arrested osteosarcoma: a case report. Cancer. 1976;37:2005–14.PubMedGoogle Scholar
  134. 134.
    Bertoni F, Unni KK, Lucas DR, McLeod RA. Osteoblastoma with cartilaginous matrix. An unusual morphologic presentation in 18 cases. Am J Surg Pathol. 1993;17(1):69–74.PubMedGoogle Scholar
  135. 135.
    McLeod RA, Dahlin DC, Beabout JW. The spectrum of osteoblastoma. Am J Roentgenol. 1976;126:321–35.Google Scholar
  136. 136.
    Berry M, Mankin H, Gebhardt M, Rosenberg A, Hornicek F. Osteoblastoma: a 30-yearstudy of 99 cases. J Surg Oncol. 2008;98:179–83.PubMedGoogle Scholar
  137. 137.
    Giannico G, Holt GE, Homlar KC, Johnson J, Pinnt J, Bridge JA. Osteoblastoma characterized by a three-way translocation: report of a case and review of the literature. Cancer Genet Cytogenet. 2009;195:168–71.PubMedGoogle Scholar
  138. 138.
    Coventry MB, Dahlin DC. Osteogenic sarcoma; a critical analysis of 430 cases. J Bone Joint Surg Am. 1957;39-A(4):741–57; discussion, 757–8.PubMedGoogle Scholar
  139. 139.
    Huvos AG. Clinicopathologic spectrum of osteogenic sarcoma. Recent observations. Pathol Annu. 1979;14 Pt 1:123–44.PubMedGoogle Scholar
  140. 140.
    Jaffe N, Frei E 3rd, Traggis D, Bishop Y. Adjuvant methotrexate and citrovorum-factor treatment of osteogenic sarcoma. N Engl J Med. 1974;291(19):994–7. No abstract available.PubMedGoogle Scholar
  141. 141.
    Dahlin DC, Unni KK. Osteosarcoma of bone and its important recognizable varieties. Am J Surg Pathol. 1977;1(1):61–72. Review.PubMedGoogle Scholar
  142. 142.
    Eilber F, Giuliano A, Eckardt J, Patterson K, Moseley S, Goodnight J. Adjuvant chemotherapy for osteosarcoma: a randomized prospective trial. J Clin Oncol. 1987;5(1):21–6.PubMedGoogle Scholar
  143. 143.
    Klein MJ, Siegal GP. Osteosarcoma: anatomic and histologic variants. Am J Clin Pathol. 2006;125(4):555–81.PubMedGoogle Scholar
  144. 144.
    Link MP, Goorin AM, Miser AW, Green AA, Pratt CB, Belasco JB, Prichard J, Malpas JS, Baker AR, Kirpatrick JA, et al. The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity. N Engl J Med. 1986;314(25):1600–6.PubMedGoogle Scholar
  145. 145.
    Raymond AK, Chawala SP, Carrasco CH, Ayala AG, Fanning TV, Grice B, Armen T, Plager C, Papadopoulos NEJ, Edeiken J, Wallace S, Jaffe N, Murray JA, Benjamin RS. Osteosarcoma chemotherapy effect: a prognostic factor. Semin Diagn Pathol. 1987;4:212–36.PubMedGoogle Scholar
  146. 146.
    Taylor WF, Ivins JC, Dahlin DC, Edmonson JH, Pritchard DJ. Trends and variability in survival from osteosarcoma. Mayo Clin Proc. 1978;53(11):695–700.PubMedGoogle Scholar
  147. 147.
    Campanacci M, Bacci G, Bertoni F, Picci P, Minutillo A, Franceschi C. The treatment of osteosarcoma of the extremities: twenty year’s experience at the Istituto Ortopedico Rizzoli. Cancer. 1981;48(7):1569–81.PubMedGoogle Scholar
  148. 148.
    Rosen G, Murphy ML, Huvos AG, Gutierrez M, Marcove RC. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma. Cancer. 1976;37(1):1–11.PubMedGoogle Scholar
  149. 149.
    Bacci G, Ferrari S, Forni C, Mercuri M, Picci P, Bertoni F, Capanna R, Manfrini M, Donati D, Brach Del Prever A, Baldini N. The effect of intra-arterial versus intravenous cisplatinum in the neoadjuvant treatment of osteosarcoma of the limbs: the experience at the Rizzoli Institute. Chir Organi Mov. 1996;81(4):369–82. English, Italian.PubMedGoogle Scholar
  150. 150.
    Rosen G, Marcove RC, Caparros B, Nirenberg A, Kosloff C, Huvos AG. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery. Cancer. 1979;43(6):2163–77.PubMedGoogle Scholar
  151. 151.
    Rosen G, Caparros B, Groshen S, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Huvos AG. Primary osteogenic sarcoma of the femur: a model for the use of preoperative chemotherapy in high risk malignant tumors. Cancer Investig. 1984;2:181–92.Google Scholar
  152. 152.
    Rosen G, Caparros B, Huvos AG, Kosloff C, Nirenberg A, Cacavio A, Marcove RC, Lane JM, Mehta B, Urban C. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer. 1982;49(6):1221–30.PubMedGoogle Scholar
  153. 153.
    Picci P, Bacci G, Campanacci M, Gasparini M, Pilotti S, Cerasoli S, Bertoni F, Guerra A, Capanna R, Albisinni U, Galletti S, Gherlinzoni F, Calderoni P, Sudanese A, Baldini N, Bernini M, Jaffe N. Histologic evaluation of necrosis in osteosarcoma induced by chemotherapy: regional mapping of viable and nonviable tumor. Cancer. 1985;56:1515–21.PubMedGoogle Scholar
  154. 154.
    Raymond AK, Ayala AG. Specimen management after osteosarcoma chemotherapy. In: Unni KK, editor. Bone tumors. New York: Churchill Livingstone; 1988.Google Scholar
  155. 155.
    Raymond AK, Ayala AG, Carrasco H, Jaffe N, Romsdahl MM, Martin RG, Murray JA, Benjamin R. Osteosarcoma preoperative chemotherapy: specimen management. Cancer Bulletin. 1990;42:317–31.Google Scholar
  156. 156.
    Raymond AK. Surface osteosarcoma. Clin Orthop Relat Res. 1991;270:140–8.Google Scholar
  157. 157.
    Raymond AK, Simms W, Ayala AG. Osteosarcoma: management following primary chemotherapy. Hematol Oncol Clin North Am. 1995;9:841–66.PubMedGoogle Scholar
  158. 158.
    Weatherby RP, Unni KK. Practical aspects of handling orthopedic specimens in the surgical pathology laboratory. Pathol Annu. 1982;17:1–31.PubMedGoogle Scholar
  159. 159.
    Cahan WG, Woodard HQ, Higinbotham NL, Stewart FW, Coley BL. Sarcoma arising in irradiated bone: report of eleven cases. Cancer. 1948;1:3–29.PubMedGoogle Scholar
  160. 160.
    Huvos AG, Woodard HQ, Cahan WG, Higinbotham NL, Stewart FW, Butler A, Bretsky SS. Postradiation osteogenic sarcoma of bone and soft tissues. A clinicopathologic study of 66 patients. Cancer. 1985;55(6):1244–55.PubMedGoogle Scholar
  161. 161.
    Inoue YZ, Frassica FJ, Sim FH, Unni KK, Petersen IA, McLeod RA. Clinicopathologic features and treatment of postirradiation sarcoma of bone and soft tissue. J Surg Oncol. 2000;75(1):42–50.PubMedGoogle Scholar
  162. 162.
    Lewis VO, Raymond K, Mirza AN, Lin P, Yasko AW. Outcome of postradiation osteosarcoma does not correlate with chemotherapy response. Clin Orthop Relat Res. 2006;450:60–6.PubMedGoogle Scholar
  163. 163.
    Sim FH, Cupps RE, Dahlin DC, Ivins JC. Postradiation sarcoma of bone. J Bone Joint Surg Am. 1972;54(7):1479–89.PubMedGoogle Scholar
  164. 164.
    Weatherby RP, Dahlin DC, Ivins JC. Postradiation sarcoma of bone: review of 78 Mayo Clinic cases. Mayo Clin Proc. 1981;56(5):294–306.PubMedGoogle Scholar
  165. 165.
    Deyrup AT, Montag AG, Inwards CY, Xu Z, Swee RG, Krishnan UK. Sarcomas arising in Paget disease of bone: a clinicopathologic analysis of 70 cases. Arch Pathol Lab Med. 2007;131(6):942–6.PubMedGoogle Scholar
  166. 166.
    McKenna RJ, Schwinn CP, Soong KY, Higinbotham NL. Osteogenic sarcoma arising in Paget’s disease. Cancer. 1964;17:42–66.PubMedGoogle Scholar
  167. 167.
    Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115(7):1531–43.  https://doi.org/10.1002/cncr.24121.CrossRefPubMedPubMedCentralGoogle Scholar
  168. 168.
    Porretta CA, Dahlin DC, Janes JM. Sarcoma in Paget’s disease of bone. J Bone Joint Surg Am. 1957;39-A(6):1314–29.PubMedGoogle Scholar
  169. 169.
    Seitz S, Priemel M, Zustin J, Beil FT, Semler J, Minne H, Schinke T, Amling M. Paget’s disease of bone: histologic analysis of 754 patients. J Bone Miner Res. 2009;24(1):62–9.  https://doi.org/10.1359/jbmr.080907.CrossRefPubMedGoogle Scholar
  170. 170.
    Hansen MF, Seton M, Merchant A. Osteosarcoma in Paget’s disease of bone. J Bone Miner Res. 2006;21 Suppl 2:P58–63. Review.PubMedGoogle Scholar
  171. 171.
    Greditzer HG 3rd, McLeod RA, Unni KK, Beabout JW. Bone sarcomas in Paget disease. Radiology. 1983;146(2):327–33.PubMedGoogle Scholar
  172. 172.
    Wick MR, Siegal GP, Unni KK, McLeod RA, Greditzer HG 3rd. Sarcomas of bone complicating osteitis deformans (Paget’s disease): fifty years’ experience. Am J Surg Pathol. 1981;5(1):47–59.PubMedGoogle Scholar
  173. 173.
    Hadjipavlou A, Lander P, Srolovitz H, Enker IP. Malignant transformation in Paget disease of bone. Cancer. 1992;70(12):2802–8.PubMedGoogle Scholar
  174. 174.
    Moore TE, King AR, Kathol MH, el-Khoury GY, Palmer R, Downey PR. Sarcoma in Paget disease of bone: clinical, radiologic, and pathologic features in 22 cases. AJR Am J Roentgenol. 1991;156(6):1199–203.PubMedGoogle Scholar
  175. 175.
    Haibach H, Farrell C, Dittrich FJ. Neoplasms arising in Paget’s disease of bone: a study of 82 cases. Am J Clin Pathol. 1985;83(5):594–600.PubMedGoogle Scholar
  176. 176.
    Jattiot F, Goupille P, Azais I, Roulot B, Alcalay M, Jeannou J, Bontoux D, Valat JP. Fourteen cases of sarcomatous degeneration in Paget’s disease. J Rheumatol. 1999;26(1):150–5.PubMedGoogle Scholar
  177. 177.
    Nellissery MJ, Padalecki SS, Brkanac Z, Singer FR, Roodman GD, Unni KK, Leach RJ, Hansen MF. Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone. Am J Hum Genet. 1998;63(3):817–24.PubMedPubMedCentralGoogle Scholar
  178. 178.
    Bertoni F, Dallera P, Bacchini P, Marchetti C, Campobassi A. The Istituto Rizzoli-Beretta experience with osteosarcoma of the jaw. Cancer. 1991;68(7):1555–63.PubMedGoogle Scholar
  179. 179.
    Clark JL, Unni KK, Dahlin DC, Devine KD. Osteosarcoma of the jaw. Cancer. 1983;51(12):2311–6.PubMedGoogle Scholar
  180. 180.
    Bennett JH, Thomas G, Evans AW, Speight PM. Osteosarcoma of the jaws: a 30-year retrospective review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90(3):323–32.PubMedGoogle Scholar
  181. 181.
    Doval DC, Kumar RV, Kannan V, Sabitha KS, Misra S, Vijay Kumar M, Hegde P, Bapsy PP, Mani K, Shenoy AM, Kumarswamy SV. Osteosarcoma of the jaw bones. Br J Oral Maxillofac Surg. 1997;35(5):357–62.PubMedGoogle Scholar
  182. 182.
    Garrington GE, Scofield HH, Cornyn J, Hooker SP. Osteosarcoma of the jaws. Analysis of 56 cases. Cancer. 1967;20(3):377–91. No abstract available.PubMedGoogle Scholar
  183. 183.
    Goepfert H, Raymond AK, Spires JR, Chawla SP, Wolf PF, Lee Y-Y, Batsakis JG. Osteosarcoma of the head and neck. Cancer Bulletin. 1990;42:347–54.Google Scholar
  184. 184.
    Guadagnolo BA, Zagars GK, Raymond AK, Benjamin RS, Sturgis EM. Osteosarcoma of the jaw/craniofacial region: outcomes after multimodality treatment. Cancer. 2009;115(14):3262–70.  https://doi.org/10.1002/cncr.24297.CrossRefPubMedGoogle Scholar
  185. 185.
    Demicco EG, Deshpande V, Nielsen GP, Kattapuram SV, Rosenberg AE. Well-differentiated osteosarcoma of the jaw bones: a clinicopathologic study of 15 cases. Am J Surg Pathol. 2010;34(11):1647–55.PubMedGoogle Scholar
  186. 186.
    Silverman G. Multiple osteosarcoma. Arch Pathol. 1936;21:88–95.Google Scholar
  187. 187.
    Mahoney JP, Spanier SS, Morris JL. Multifocal osteosarcoma: a case report with review of the literature. Cancer. 1979;44:1897–907.PubMedGoogle Scholar
  188. 188.
    Parham DM, Pratt CB, Parvey LS, Webber BL, Champion JC. Childhood multifocal osteosarcoma. Clinicopathologic and radiologic correlates. Cancer. 1985;55:2653–8.PubMedGoogle Scholar
  189. 189.
    Corradi D, Wenger DE, Bertoni F, Bacchini P, Bosio S, Goldoni M, Unni KK, Sim FH, Inwards CY. Multicentric osteosarcoma: clinicopathologic and radiographic study of 56 cases. Am J Clin Pathol. 2011;136(5):799–807.PubMedGoogle Scholar
  190. 190.
    Unni KK, Dahlin DC, McLeod RA, Pritchard DJ. Intraosseous well-differentiated osteosarcoma. Cancer. 1977;40:1337–47.PubMedGoogle Scholar
  191. 191.
    Campanacci M, Bertoni F, Capanna R, Cervellati C. Central osteosarcoma of low grade malignancy. Ital J Orthop Traurnatol. 1981;7:71–8.Google Scholar
  192. 192.
    Kurt AM, Unni KK, McLeod RA, Prichard DJ. Low-grade intraosseous osteosarcoma. Cancer. 1990;65(6):1418–28.PubMedGoogle Scholar
  193. 193.
    Okada K, Nishida J, Morita T, Kakizaki H, Ishikawa A, Hotta T. Low-grade intraosseous osteosarcoma in northern Japan: advantage of AgNOR and MIB-1 staining in differential diagnosis. Hum Pathol. 2000;31(6):633–9.PubMedGoogle Scholar
  194. 194.
    Xipell JM, Rush J. Case report. 340. Well- differentiated intraosseous osteosarcoma of the left femur. Skelet Radiol. 1985;14:312–6.Google Scholar
  195. 195.
    Yoshida A, Ushiku T, Motoi T, et al. Immunohistochemical analysis of MDM2 and CDK4 distinguishes low-grade osteosarcoma from benign mimics. Mod Pathol. 2010;23:1279–88.PubMedGoogle Scholar
  196. 196.
    Farr GH, Huvos AG, Marcove RC, Higinbotham NL, Foote FW Jr. Telangiectatic osteogenic sarcoma. A review of twenty-eight cases. Cancer. 1974;34(4):1150–8.PubMedGoogle Scholar
  197. 197.
    Matsuno T, Unni KK, McLeod RA, Dahlin DC. Telangiectatic osteogenic sarcoma. Cancer. 1976;38:2538–47.PubMedGoogle Scholar
  198. 198.
    Bacci G, Ferrari S, Ruggieri P, Biagini R, Fabbri N, Campanacci L, Bacchini P, Longhi A, Forni C, Bertoni F. Telangiectatic osteosarcoma of the extremity: neoadjuvant chemotherapy in 24 cases. Acta Orthop Scand. 2001;72:167–72.PubMedGoogle Scholar
  199. 199.
    Chawla SP, Benjamin RS. Effectiveness of chemotherapy in the management of metastatic telangiectatic osteosarcoma. Am J Clin Oncol. 1988;11:177–80.PubMedGoogle Scholar
  200. 200.
    Huvos AG, Rosen G, Bretsky SS, Butler A. Telangiectatic osteogenic sarcoma: a clinicopathologic study of 124 patients. Cancer. 1982;49:1679–89.PubMedGoogle Scholar
  201. 201.
    Larsson SE, Lorentzon R, Boquist L. Telangiectatic osteosarcoma. Acta Orthop Scand. 1978;49:589–94.PubMedGoogle Scholar
  202. 202.
    Weiss A, Khoury JD, Hoffer FA, Wu J, Billups CA, Heck RK, Quintana J, Poe D, Rao BN, Daw NC. Telangiectatic osteosarcoma: the St. Jude Children’s Research Hospital’s experience. Cancer. 2007;109:1627–37.PubMedGoogle Scholar
  203. 203.
    Rosen G, Huvos AG, Marcove R, Nirenberg A. Telangiectatic osteogenic sarcoma: improved survival with combination chemotherapy. Clin Orthop. 1986;207:164–73.Google Scholar
  204. 204.
    Murphey MD, wan Jaovisidha S, Temple HT, Gannon FH, Jelinek JS, Malawer MM. Telangiectatic osteosarcoma: radiologic-pathologic comparison. Radiology. 2003;229:545–53.PubMedGoogle Scholar
  205. 205.
    Sangle NA, Layfield LJ. Telangiectatic osteosarcoma. Arch Pathol Lab Med. 2012;136:572–6.PubMedGoogle Scholar
  206. 206.
    Sim FH, Unni KK, Beabout JW, Dahlin DC. Osteosarcoma with small cells simulating Ewing’s tumor. J Bone Joint Surg Am. 1979;61(2):207–15.PubMedGoogle Scholar
  207. 207.
    Righi A, Gambarotti M, Longo S, Benini S, Gamberi G, Cocchi S, Vanel D, Picci P, Bertoni F, Simoni A, Franchi A, Dei Tos AP. Small cell osteosarcoma: clinicopathologic, immunohistochemical, and molecular analysis of 36 cases. Am J Surg Pathol. 2015;39(5):691–9.  https://doi.org/10.1097/PAS.0000000000000412.CrossRefPubMedGoogle Scholar
  208. 208.
    Ayala AG, Ro JY, Raymond AK, Jaffe N, Chawla S, Carrasco H, Link M, Jimenez J. Small cell osteosarcoma. A clinicopathologic study of 27 cases. Cancer. 1989;64(10):2162–73.PubMedGoogle Scholar
  209. 209.
    Noguera R, Navarro S, Triche TJ. Translocation (11;22) in small cell osteosarcoma. Cancer Genet Cytogenet. 1990;45(1):121–4. No abstract available.PubMedGoogle Scholar
  210. 210.
    Edeiken J, Raymond AK, Ayala AG, Benjamin RS, Murray JA, Carrasco HC. Small cell osteosarcoma. Skelet Radiol. 1987;16(8):621–8. Review.Google Scholar
  211. 211.
    Bertoni F, Present D, Bacchini P, Pignatti G, Picci P, Campanacci M. The Istituto Rizzoli experience with small cell osteosarcoma. Cancer. 1989;64(12):2591–9. Review.PubMedGoogle Scholar
  212. 212.
    Dickersin GR, Rosenberg AE. The ultrastructure of small-cell osteosarcoma with a review of the light microscopy and differential diagnosis. Hum Pathol. 1991;22(3):267–75.PubMedGoogle Scholar
  213. 213.
    Martin SE, Dwyer A, Kissane JM, Costa J. Small-cell osteosarcoma. Cancer. 1982;50(5):990–6.PubMedGoogle Scholar
  214. 214.
    Geschickter CF, Copeland MM. Parosteal osteoma of bone: a new entity. Ann Surg. 1951;133:790–807.PubMedPubMedCentralGoogle Scholar
  215. 215.
    Dwinnell LA, Dahlin DC, Ghormley RK. Parosteal (juxtacortical) osteogenic sarcoma. J Bone Joint Surg. 1954;36A:732–44.Google Scholar
  216. 216.
    Edeiken J, Farrell C, Ackerman LV, Spjut HJ. Parosteal sarcoma. Am J Roentgenol Radium Ther Nucl Med. 1971;111(3):579–83.PubMedGoogle Scholar
  217. 217.
    Kaste SC, Fuller CE, Saharia A, Neel MD, Rao BN, Daw NC. Pediatric surface osteosarcoma: clinical, pathologic, and radiologic features. Pediatr Blood Cancer. 2006;47(2):152–62.PubMedGoogle Scholar
  218. 218.
    Campanacci M, Picci P, Gherlinzoni F, Guerra A, Neff JR. Parosteal osteosarcoma. J Bone Joint Surg Br. 1984;66:313–21.PubMedGoogle Scholar
  219. 219.
    Picci P, Campanacci M, Bacci G, Capanna R, Ayala A. Medullary involvement in parosteal osteosarcoma. J Bone Joint Surg Am. 1987;69(1):131–6.PubMedGoogle Scholar
  220. 220.
    Campanacci M, Capanna R, Stilli S. Posterior hemiresection of the distal femur in parosteal osteosarcoma. Ital J Orthop Traumatol. 1982;8(1):23–8.PubMedGoogle Scholar
  221. 221.
    Laitinen M, Parry M, Albergo JI, Jeys L, Abudu A, Carter S, Sumathi V, Grimer R. The prognostic and therapeutic factors which influence the oncological outcome of parosteal osteosarcoma. Bone Joint J. 2015;97-B(12):1698–703.PubMedGoogle Scholar
  222. 222.
    Duhamel LA, Ye H, Halai D, Idowu BD, Presneau N, Tirabosco R, Flanagan AM. Frequency of Mouse Double Minute 2 (MDM2) and Mouse Double Minute 4 (MDM4) amplification in parosteal and conventional osteosarcoma subtypes. Histopathology. 2012;60(2):357–9.PubMedGoogle Scholar
  223. 223.
    Heidenblad M, Hallor KH, Staaf J, Jönsson G, Borg Å, Höglund M, Mertens F, Mandahl N. Genomic profiling of bone and soft tissue tumors with supernumerary ring chromosomes using tiling resolution bacterial artificial chromosome microarrays. Oncogene. 2006;25:7106–16.PubMedGoogle Scholar
  224. 224.
    Ahuja SC, Villacin AB, Smith J, Bullough PG, Huvos AG, Marcove RC. Juxtacortical (parosteal) osteogenic sarcoma: histological grading and prognosis. J Bone Joint Surg Am. 1977;59(5):632–47.PubMedGoogle Scholar
  225. 225.
    Stevens GM, Pugh DG, Dahlin DC. Roentgenographic recognition and differentiation of parosteal osteogenic sarcoma. Am J Roentgenol Radium Ther Nucl Med. 1957;78(1):1–12.PubMedGoogle Scholar
  226. 226.
    Bertoni F, Present D, Hudson T, Enneking WF. The meaning of radiolucencies in parosteal osteosarcoma. J Bone Joint Surg. 1985;67A:901–10.Google Scholar
  227. 227.
    Sheth DS, Yasko AW, Raymond AK, Ayala AG, Carrasco CH, Benjami RS, Jaffe N, Murray JA. Conventional and dedifferentiated parosteal osteosarcoma. Cancer. 1996;78(10):2136–45.PubMedGoogle Scholar
  228. 228.
    Lindell MM Jr, Shirkhoda A, Raymond AK, Murray JA, Harle TS. Parosteal osteosarcoma: radiologic-pathologic correlation with emphasis on CT. AJR Am J Roentgenol. 1987;148(2):323–8.PubMedGoogle Scholar
  229. 229.
    Wold LE, Unni KK, Beabout JW, Sim FH, Dahlin DC. Dedifferentiated parosteal osteosarcoma. J Bone Joint Surg Am. 1984;66(1):53–9.PubMedGoogle Scholar
  230. 230.
    Bertoni FI, Bacchini P, Staals EL, Davidovitz P. Dedifferentiated parosteal osteosarcoma: the experience of the Rizzoli institute. Cancer. 2005;103(11):2373–82.PubMedGoogle Scholar
  231. 231.
    Azura M, Vanel D, Alberghini M, Picci P, Staals E, Mercuri M. Parosteal osteosarcoma dedifferentiating into telangiectatic osteosarcoma: importance of lytic changes and fluid cavities at imaging. Skelet Radiol. 2009;38(7):685–90.  https://doi.org/10.1007/s00256-009-0672-3. Epub 2009 Mar 7.CrossRefGoogle Scholar
  232. 232.
    Cardona DM, Knapik JA, Reith JD. Dedifferentiated parosteal osteosarcoma with giant cell tumor component. Skelet Radiol. 2008;37(4):367–71.  https://doi.org/10.1007/s00256-007-0440-1. Epub 2008 Feb 7.CrossRefGoogle Scholar
  233. 233.
    Shuhaibar H, Friedman L. Dedifferentiated parosteal osteosarcoma with high-grade osteoclast-rich osteogenic sarcoma at presentation. Skelet Radiol. 1998;27(10):574–7. Review.Google Scholar
  234. 234.
    Dönmez FY, Tüzün U, Başaran C, Tunaci M, Bilgiç B, Acunaş G. MRI findings in parosteal osteosarcoma: correlation with histopathology. Diagn Interv Radiol. 2008;14(3):142–52.PubMedGoogle Scholar
  235. 235.
    Unni KK, Dahlin DC, Beabout JW. Periosteal osteogenic sarcoma. Cancer. 1976;37:2476–85.PubMedGoogle Scholar
  236. 236.
    Campanacci M, Giunti A. Periosteal osteosarcoma review of 41 cases, 22 with long-term follow-up. Ital J Orthop Traumatol. 1976;2:23–35.PubMedGoogle Scholar
  237. 237.
    Spjut HJ, Ayala AG, deSantos LA, et al. Periosteal osteosarcoma. In: Management of primary bone and soft tissue tumors. St. Louis: Mosby; 1977.Google Scholar
  238. 238.
    Grimer RJ, Bielack S, Flege S, Cannon SR, Foleras G, Andreeff I, Sokolov T, Taminiau A, Dominkus M, San-Julian M, Kollender Y, Gosheger G, European Musculo Skeletal Oncology Society. Periosteal osteosarcoma—a European review of outcome. Eur J Cancer. 2005;41:2806–11.PubMedGoogle Scholar
  239. 239.
    Ritts GD, Pritchard DJ, Unni KK, Beabout JW, Eckardt JJ. Periosteal osteosarcoma. Clin Orthop. 1987;219:299–307.Google Scholar
  240. 240.
    Cesari M, Albergini M, Vanel D, Palmerini E, Stalls EL, Longhi A, Abate M, Ferrari C, Balladelli A, Ferrari S. Periosteal osteosarcoma: a single-institution experience. Cancer. 2011;117(8):1731–5.PubMedGoogle Scholar
  241. 241.
    Rose PS, Dickey ID, Wenger DE, Unni KK, Sim FH. Periosteal osteosarcoma: long-term outcome and risk of late recurrence. Clin Orthop Relat Res. 2006;453:314–7.PubMedGoogle Scholar
  242. 242.
    Murphey MD, Jelinek JS, Temple HT, Flemming DJ, Gannon FH. Imaging of periosteal osteosarcoma: radiologic-pathologic comparison. Radiology. 2004;233:129–38.PubMedGoogle Scholar
  243. 243.
    Righi A, Gambarotti M, Benini S, Gamberi G, Cocchi S, Picci P, Bertoni F. MDM2 and CDK4 expression in periosteal osteosarcoma. Hum Pathol. 2015;46(4):549–53.PubMedGoogle Scholar
  244. 244.
    deSantos LA, Murray JA, Finklestein JB, Spjut HJ, Ayala AG. The radiographic spectrum of periosteal osteosarcoma. Radiology. 1978;127:123–9.PubMedGoogle Scholar
  245. 245.
    Wold LE, Unni KK, Raymond AK, Dahlin DC. High grade surface osteosarcoma. Lab Invest. 1983;48:94A. (abstract).Google Scholar
  246. 246.
    Wold LE, Unni KK, Beabout JW, Pritchard DJ. High grade surface osteosarcomas. Am J Surg Pathol. 1984;8:181–6.PubMedGoogle Scholar
  247. 247.
    Abe K, Kumagai K, Hayashi T, Kinoshita N, Shindo H, Uetani M, Ishida T. High-grade surface osteosarcoma of the hand. Skeletal Radiol. 2007;36(9):869–73.PubMedGoogle Scholar
  248. 248.
    Staals EL, Bacchini P, Bertoni F. High-grade surface osteosarcoma: a review of 25 cases from the Rizzoli Institute. Cancer. 2008;112(7):1592–9.PubMedGoogle Scholar
  249. 249.
    Okada K, Unni KK, Swee RG, Sim FH. High grade surface osteosarcoma: a clinicopathologic study of 46 cases. Cancer. 1999;85(5):1044–54.PubMedGoogle Scholar
  250. 250.
    Hoshi M, Matsumoto S, Manabe J, et al. Report of four cases with high-grade surface osteosarcoma. Jpn J Clin Oncol. 2006;36:180–4.PubMedGoogle Scholar
  251. 251.
    Sonneland PR, Unni KK. Case report 258: high-grade “surface” osteosarcoma arising from the femoral shaft. Skelet Radiol. 1984;11:77–80.Google Scholar
  252. 252.
    Vanel D, Picci P, De Paolis M, Mercuri M. Radiological study of 12 high-grade surface osteosarcomas. Skelet Radiol. 2001;30(12):667–71.Google Scholar
  253. 253.
    Lichtenstein L, Jaffe HL. Eosinophilic granuloma of bone: with report of a case. Am J Pathol. 1940;16(5):595–604.PubMedPubMedCentralGoogle Scholar
  254. 254.
    Lichtenstein L. Histiocytosis X; integration of eosinophilic granuloma of bone, Letterer-Siwe disease, and Schüller-Christian disease as related manifestations of a single nosologic entity. AMA Arch Pathol. 1953;56(1):84–102.PubMedGoogle Scholar
  255. 255.
    Lieberman PH, Jones CR, Steinman RM, Erlandson RA, Smith J, Gee T, Huvos A, Garin-Chesa P, Filippa DA, Urmacher C, Gangi MD, Sperber M. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years. Am J Surg Pathol. 1996;20(5):519–52.PubMedGoogle Scholar
  256. 256.
    Wester SM, Beabout JW, Unni KK, Dahlin DC. Langerhans’ cell granulomatosis (histiocytosis X) of bone in adults. Am J Surg Pathol. 1982;6(5):413–26.PubMedGoogle Scholar
  257. 257.
    Zeng K, Ohshima K, Liu Y, Zhang W, Wang L, Fan L, Li M, Li X, Wang Z, Guo S, Yan Q, Guo Y. BRAFV600E and MAP2K1 mutations in Langerhans cell histiocytosis occur predominantly in children. Hematol Oncol. 2017;35(4):845–51.  https://doi.org/10.1002/hon.2344. Epub 2016 Sep 6.CrossRefPubMedGoogle Scholar
  258. 258.
    Oberling C. Les reticulosarcomes et les reticuloendotheliosarcomes de la moelle osseuse (sarcomes d’Ewing). Bull Assoc Fr Cancer. 1928;17:259–96.Google Scholar
  259. 259.
    Boston HC, Dahlin DC, Ivans JC, Cupps RE. Malignant lymphoma (so-called reticulum cell sarcoma) of bone. Cancer. 1974;34(4):1131–7.PubMedGoogle Scholar
  260. 260.
    Dosoretz DE, Raymond AK, Murphy GF, Doppke KP, Schiller AL, Wang CC, Suit HD. Primary lymphoma of bone: the relationship of morphologic diversity to clinical behavior. Cancer. 1982;50(5):1009–14.PubMedGoogle Scholar
  261. 261.
    Ivins JC, Dahlin DC. Malignant lymphoma (reticulum sarcoma) of bone. Proc Staff Meet Mayo Clin. 1963;38:375–85. No abstract available.PubMedGoogle Scholar
  262. 262.
    Parker F, Jackson H. Primary reticulum cell sarcoma of bone. Surg Gynecol Obstet. 1939;68:45–53.Google Scholar
  263. 263.
    Heyning FH, Hogendoorn PC, Kramer MH, Hermans J, Kluin-Nelemans JC, Noordijk EM, Kluin PM. Primary non-Hodgkin’s lymphoma of bone: a clinicopathological investigation of 60 cases. Leukemia. 1999;13(12):2094–8.PubMedGoogle Scholar
  264. 264.
    Mertens F, Romeo S, Bovée JV, Tirabosco R, Athanasou N, Alberghini M, Hogendoorn PC, Dei Tos AP, Sciot R, Domanski HA, Aström K, Mandahl N, Debiec-Rychter M. Reclassification and subtyping of so-called malignant fibrous histiocytoma of bone: comparison with cytogenetic features. Clin Sarcoma Res. 2011;1(1):10.PubMedPubMedCentralGoogle Scholar
  265. 265.
    Li X, Xu-Monette ZY, Yi S, Dabaja BS, Manyam GC, Westin J, Fowler N, Miranda RN, Zhang M, Ferry JA, Medeiros LJ, Harris NL, Young KH. Primary bone lymphoma exhibits a favorable prognosis and distinct gene expression signatures resembling diffuse large B-cell lymphoma derived from centrocytes in the germinal center. Am J Surg Pathol. 2017;41(10):1309–21.PubMedGoogle Scholar
  266. 266.
    Ewing J. The classic: diffuse endothelioma of bone. Proceedings of the New York Pathological Society. 1921;12:17. Clin Orthop Relat Res. 2006;450:25–7.PubMedGoogle Scholar
  267. 267.
    Ewing J. Diffuse endothelioma of bone. Proc NY Pathol Soc. 1921;21:17–24.Google Scholar
  268. 268.
    Fletcher CDM, Bridge JA, Hogerndoorn PCW. WHO classification of Tumours of soft tissue and bone. 4th ed. Geneva: Editors Fredrik Mertens. WHO Press; 2013.Google Scholar
  269. 269.
    Wilkins RM, Pritchard DJ, Burgert EO Jr, Unni KK. Ewing’s sarcoma of bone. Experience with 140 patients. Cancer. 1986;58(11):2551–5.PubMedGoogle Scholar
  270. 270.
    Bacci G, Longhi A, Barbieri E, Ferrari S, Mercuri M, Briccoli A, Versari M, Pignotti E, Picci P. Second malignancy in 597 patients with Ewing sarcoma of bone treated at a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999. J Pediatr Hematol Oncol. 2005;27(10):517–20.PubMedGoogle Scholar
  271. 271.
    Park YK, Chi SG, Park HR, Yang MH, Unni KK. Detection of t(11;22)(q24;q12) translocation of Ewing’s sarcoma in paraffin embedded tissue by nested reverse transcription-polymerase chain reaction. J Korean Med Sci. 1998;13(4):395–9.PubMedPubMedCentralGoogle Scholar
  272. 272.
    Nascimento AG, Unii KK, Pritchard DJ, Cooper KL, Dahlin DC. A clinicopathologic study of 20 cases of large-cell (atypical) Ewing’s sarcoma of bone. Am J Surg Pathol. 1980;4(1):29–36.PubMedGoogle Scholar
  273. 273.
    Dahlin DC, Coventry MB, Scanlon PW. Ewing’s sarcoma. A critical analysis of 165 cases. J Bone Joint Surg Am. 1961;43-A:185–92.PubMedGoogle Scholar
  274. 274.
    Romeo S, Bovée JV, Kroon HM, Tirabosco R, Natali C, Zanatta L, Sciot R, Mertens F, Athanasou N, Alberghini M, Szuhai K, Hogendoorn PC, Dei Tos AP. Malignant fibrous histiocytoma and fibrosarcoma of bone: a re-assessment in the light of currently employed morphological, immunohistochemical and molecular approaches. Virchows Arch. 2012;461(5):561–70.  https://doi.org/10.1007/s00428-012-1306-z. Epub 2012 Sep 22.CrossRefPubMedGoogle Scholar
  275. 275.
    Inwards CY, Unni KK, Beabout JW, Sim FH. Desmoplastic fibroma of bone. Cancer. 1991;68(9):1978–83.PubMedGoogle Scholar
  276. 276.
    Jaffe HL. Tumors and tumorous conditions of the bones and joints. In: Lea&Febiger, editor. Tumors and tumorous conditions of the bones and joints. Philadelphia: Lea & Febiger; 1958.Google Scholar
  277. 277.
    Nedopil A, Raab P, Rudert M. Desmoplastic fibroma: a case report with three years of clinical and radiographic observation and review of the literature. Open Orthop J. 2013;8:40–6.PubMedPubMedCentralGoogle Scholar
  278. 278.
    Hauben EI, Jundt G, Cleton-Jansen AM, Yavas A, Kroon HM, Van Marck E, Hogendoorn PC. Desmoplastic fibroma of bone: an immunohistochemical study including beta-catenin expression and mutational analysis for beta-catenin. Hum Pathol. 2005;36(9):1025–30.PubMedGoogle Scholar
  279. 279.
    Frick MA, Sundaram M, Unni KK, Inwards CY, Fabbri N, Trentani F, Baccini P, Bertoni F. Imaging findings in desmoplastic fibroma of bone: distinctive T2 characteristics. AJR Am J Roentgenol. 2005;184(6):1762–7.PubMedGoogle Scholar
  280. 280.
    Gebhardt MC, Campbell CJ, Schiller AL, Mankin HJ. Desmoplastic fibroma of bone. A report of eight cases and review of the literature. J Bone Joint Surg Am. 1985;67(5):732–47.PubMedGoogle Scholar
  281. 281.
    Papagelopoulos PJ, Galanis E, Frassica FJ, Sim FH, Larson DR, Wold LE. Primary fibrosarcoma of bone. Outcome after primary surgical treatment. Clin Orthop Relat Res. 2000;373:88–103.Google Scholar
  282. 282.
    Papagelopoulos PJ, Galanis EC, Trantafyllidis P, Boscainos PJ, Sim FH, Unni KK. Clinicopathologic features, diagnosis, and treatment of fibrosarcoma of bone. Am J Orthop (Belle Mead NJ). 2002;31(5):253–7. Review.Google Scholar
  283. 283.
    Bertoni F, Capanna R, Calderoni P, Patrizia B, Campanacci M. Primary central (medullary) fibrosarcoma of bone. Semin Diagn Pathol. 1984;1(3):185–98.PubMedGoogle Scholar
  284. 284.
    Jaffe HL, Lichtenstein L. Non-osteogenic fibroma of bone. Am J Pathol. 1942;28:205–21.Google Scholar
  285. 285.
    Campanacci M, Laus M, Boriani S. Multiple non-ossifying fibromata with extraskeletal anomalies: a new syndrome? J Bone Joint Surg Br. 1983;65:627–32.PubMedGoogle Scholar
  286. 286.
    Mirra JM, Gold RH, Rand F. Disseminated nonossifying fibromas in association with café-au-lait spots (Jaffe-Campanacci syndrome). Clin Orthop Relat Res. 1982;168:192–205.Google Scholar
  287. 287.
    Arata MA, Peterson HA, Dahlin DC. Pathological fractures through nonossifying fibromas: review of the Mayo Clinic experience. J Bone Joint Surg Am. 1981;63:980–8.PubMedGoogle Scholar
  288. 288.
    Mankin HJ, Trahan CA, Fondren G, Mankin CJ. Non-ossifying fibroma, fibrous cortical defect and Jaffe-Campanacci syndrome: a biologic and clinical review. Chir Organi Mov. 2009;93:1–7.PubMedGoogle Scholar
  289. 289.
    Betsy M, Kupersmith LM, Springfield DS. Metaphyseal fibrous defects. J Am Acad Orthop Surg. 2004;12:89–95.PubMedGoogle Scholar
  290. 290.
    Bhagwandeen SB. Malignant transformation of a non-osteogenic fibroma of bone. J Pathol Bacteriol. 1966;92:562–4; Glockenberg A, Sobel E, Noel JF. Nonossifying fibroma. Four cases and review of the literature. J Am Podiatr Med Assoc. 1977;87:66–9.Google Scholar
  291. 291.
    Nelson M, Perry D, Ginsburg G, Sanger WG, Neff JR, Bridge JA. Translocation (1;4)(p31;q34) in nonossifying fibroma. Cancer Genet Cytogenet. 2003;142:142–4.PubMedGoogle Scholar
  292. 292.
    Jee WH, Choe BY, Kang HS, Suh KJ, Ryu KN, Lee YS, Ok IY, Kim JM, Choi KH, Shinn KS. Nonossifying fibroma: characteristics at MR imaging with pathologic correlation. Radiology. 1998;209:197–202.PubMedGoogle Scholar
  293. 293.
    Ritschl P, Hajek PC, Pechmann U. Fibrous metaphyseal defects: magnetic resonance imaging appearances. Skeletal Radiol. 1989;18:253–9. PMID: 2781323.PubMedGoogle Scholar
  294. 294.
    Ponset IV, Friedman B. Evolution of metaphyseal fibrous defects. J Bone Joint Surg. 1949;31:582.Google Scholar
  295. 295.
    Moser RP Jr, Sweet DE, Haseman DB, et al. Multiple skeletal fibroxanthomas: radiologic-pathologic correlation of 72 cases. Skelet Radiol. 1987;16:353–9. PMID: 3629279.Google Scholar
  296. 296.
    Capanna R, Bertoni F, Bacchini P, Bacci G, Guerra A, Campanacci M. Malignant fibrous histiocytoma of bone. The experience at the Rizzoli Institute: report of 90 cases. Cancer. 1984;54(1):177–87.PubMedGoogle Scholar
  297. 297.
    Dahlin DC, Unni KK, Matsuno T. Malignant (fibrous) histiocytoma of bone-fact or fancy? Cancer. 1977;39(4):1508–16.PubMedGoogle Scholar
  298. 298.
    Feldman F, Norman D. Intra- and extraosseous malignant histiocytoma (malignant fibrous xanthoma). Radiology. 2013;1972:497–9.Google Scholar
  299. 299.
    Huvos AG, Heilweil M, Bretsky SS. The pathology of malignant fibrous histiocytoma of bone. A study of 130 patients. Am J Surg Pathol. 1985;9(12):853–71.PubMedGoogle Scholar
  300. 300.
    Papagelopoulos PJ, Galanis EC, Sim FH, Unni KK. Clinicopathologic features, diagnosis, and treatment of malignant fibrous histiocytoma of bone. Orthopedics. 2000;23(1):59–65; quiz 66–7.PubMedGoogle Scholar
  301. 301.
    Nooij MA, Whelan J, Bramwell VH, Taminiau AT, Cannon S, Hogendoorn PC, Pringle J, Uscinska BM, Weeden S, Kirkpatrick A, Glabbeke M, Craft AW, European Osteosarcoma Intergroup. Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. Eur J Cancer. 2005;41(2):225–30.PubMedGoogle Scholar
  302. 302.
    Bacci G, Ferrari S, Bertoni F, Mercuri M, Forni C, Sottili S, Gasbarrini A, Tienghi A, Cesari M, Campanacci M. Neoadjuvant chemotherapy for osseous malignant fibrous histiocytoma of the extremity: results in 18 cases and comparison with 112 contemporary osteosarcoma patients treated with the same chemotherapy regimen. J Chemother. 1997;9(4):293–9.PubMedGoogle Scholar
  303. 303.
    Lichtenstein L, Jaffe HL. Fibrous dysplasia of a bone: condition affecting one, several or many bones, graver cases of which may present abnormal pigmentation of skin, premature sexual development, hyperthyroidism or still other extraskeletal abnormalities. Arch Pathol. 1942;33:777.Google Scholar
  304. 304.
    Dorfman HD. New knowledge of fibro-osseous lesions of bone. Int J Surg Pathol. 2010;18(3 Suppl):62S–5S.PubMedGoogle Scholar
  305. 305.
    Lichtenstein L. Polyostotic fibrous dysplasia. Arch Surg. 1938;36:874–98.Google Scholar
  306. 306.
    DiCaprio MR, Enneking WF. Fibrous dysplasia. Pathophysiology, evaluation, and treatment. J Bone Joint Surg Am. 2005;87:1848–64.PubMedGoogle Scholar
  307. 307.
    Ruggieri P, Sim FH, Bond JR, Unni KK. Malignancies in fibrous dysplasia. Cancer. 1994;73:1411–24.PubMedGoogle Scholar
  308. 308.
    Morioka H, Kamata Y, Nishimoto K, Susa M, Kikuta K, Horiuchi K, Sasaki A, Kameyama K, Nakamura M, Matsumoto M. Fibrous dysplasia with massive cartilaginous differentiation (fibrocartilaginous dysplasia) in the proximal femur: a case report and review of the literature. Case Rep Oncol. 2016;9(1):126–33.PubMedPubMedCentralGoogle Scholar
  309. 309.
    Dal Cin P, Sciot R, Brys P, et al. Recurrent chromosome aberrations in fibrous dysplasia of the bone: a report of the CHAMP study group. CHromosomes And MorPhology. Cancer Genet Cytogenet. 2000;122:30–2.PubMedGoogle Scholar
  310. 310.
    Campanacci M. Osteofibrous dysplasia of long bones a new clinical entity. Ital J Orthop Traumatol. 1976;2(2):221–37.PubMedGoogle Scholar
  311. 311.
    Park YK, Unni KK, McLeod RA, Pritchard DJ. Osteofibrous dysplasia: clinicopathologic study of 80 cases. Hum Pathol. 1993;24(12):1339–47.PubMedGoogle Scholar
  312. 312.
    Campbell CJ, Hawk T. A variant of fibrous dysplasia (osteofibrous dysplasia). J Bone Joint Surg Am. 1982;64(2):231–6.PubMedGoogle Scholar
  313. 313.
    Kempson RL. Ossifying fibroma of the long bones. A light and electron microscopic study. Arch Pathol. 1966;82(3):218–33.PubMedGoogle Scholar
  314. 314.
    Sweet DE, Vinh TN, Devaney K. Cortical osteofibrous dysplasia of long bone and its relationship to adamantinoma. A clinicopathologic study of 30 cases. Am J Surg Pathol. 1992;16(3):282–90.PubMedGoogle Scholar
  315. 315.
    Kamineni S, Briggs TW, Saifuddin A, Sandison A. Osteofibrous dysplasia of the ulna. J Bone Joint Surg Br. 2001;83(8):1178–80.PubMedGoogle Scholar
  316. 316.
    Most MJ, Sim FH, Inwards CY. Osteofibrous dysplasia and adamantinoma. J Am Acad Orthop Surg. 2010;18(6):358–66.PubMedGoogle Scholar
  317. 317.
    Nakashima Y, Yamamuro T, Fujiwara Y, Kotoura Y, Mori E, Hamashima Y. Osteofibrous dysplasia (ossifying fibroma of long bones). A study of 12 cases. Cancer. 1983;52(5):909–14.PubMedGoogle Scholar
  318. 318.
    Ishida T, Iijima T, Kikuchi F, Kitagamwa T, Imamura T, Machinami R. A clinicopathological and immunohistochemical study of osteofibrous dysplasia, differentiated adamantinoma, and adamantinoma of long bones. Skelet Radiol. 1992;21(8):493–502.Google Scholar
  319. 319.
    Jung JY, Jee WH, Hong SH, Kang HS, Chung HW, Ryu KN, Kim JY, Im SA, Park JM, Sung MS, Lee YS, Hong SJ, Jung CK, Chung YG. MR findings of the osteofibrous dysplasia. Korean J Radiol. 2014;15(1):114–22.  https://doi.org/10.3348/kjr.2014.15.1.114.CrossRefPubMedPubMedCentralGoogle Scholar
  320. 320.
    Bridge JA, Dembinski A, DeBoer J, Travis J, Neff JR. Clonal chromosomal abnormalities in osteofibrous dysplasia. Implications for histopathogenesis and its relationship with adamantinoma. Cancer. 1994;73(6):1746–52.PubMedGoogle Scholar
  321. 321.
    Gleason BC, Liegl-Atzwanger B, Kozakewich HP, Connolly S, Gebhardt MC, Fletcher JA, Perez-Atayde AR. Osteofibrous dysplasia and adamantinoma in children and adolescents: a clinicopathologic reappraisal. Am J Surg Pathol. 2008;32(3):363–76.  https://doi.org/10.1097/PAS.0b013e318150d53e.CrossRefPubMedGoogle Scholar
  322. 322.
    Hazelbag HM, Taminiau AH, Fleuren GJ, Hogendoorn PC. Adamantinoma of the long bones. A clinicopathological study of thirty-two patients with emphasis on histological subtype, precursor lesion, and biological behavior. J Bone Joint Surg Am. 1994;76(10):1482–99.PubMedGoogle Scholar
  323. 323.
    Simoni P, Scarciolla L, Mutijima E, Zobel BB. Osteofibrous dysplasia: a case report and review of the literature. Radiol Case Rep. 2011;6:1–3.Google Scholar
  324. 324.
    Hazelbag HM, Hogendoorn PC. Adamantinoma of the long bones: an anatomo-clinical review and its relationship with osteofibrous dysplasia. Ann Pathol. 2001;21(6):499–511.PubMedGoogle Scholar
  325. 325.
    Ueda Y, Roessner A, Bosse A, Edel G, Böcker W, Wuisman P. Juvenile intracortical adamantinoma of the tibia with predominant osteofibrous dysplasia-like features. Pathol Res Pract. 1991;187(8):1039–43; discussion 1043–4.PubMedGoogle Scholar
  326. 326.
    Bridge JA, Swarts SJ, Buresh C, Nelson M, Degenhardt JM, Spanier S, Maale G, Meloni A, Lynch JC, Neff JR. Trisomies 8 and 20 characterize a subgroup of benign fibrous lesions arising in both soft tissue and bone. Am J Pathol. 1999;154(3):729–33.PubMedPubMedCentralGoogle Scholar
  327. 327.
    Sakamoto A, Oda Y, Iwamoto Y, et al. A comparative study of fibrous dysplasia and osteofibrous dysplasia with regard to Gs-alpha mutation at the Arg201 codon: polymerase chain reaction-restriction fragment length polymorphism analysis of paraffin-embedded tissues. J Mol Diagn. 2000;2:67–72.PubMedPubMedCentralGoogle Scholar
  328. 328.
    Springfield DS, Rosenberg AE, Mankin HJ, Mindell ER. Relationship between osteofibrous dysplasia and adamantinoma. Clin Orthop Relat Res. 1994;309:234–44.Google Scholar
  329. 329.
    Taylor RM, Kashima TG, Ferguson DJ, Szuhai K, Hogendoorn PC, Athanasou NA. Analysis of stromal cells in osteofibrous dysplasia and adamantinoma of long bones. Mod Pathol. 2012;25(1):56–64.  https://doi.org/10.1038/modpathol.2011.141.CrossRefPubMedGoogle Scholar
  330. 330.
    Nakahara H, Kunisada T, Noda T, Ozaki T. Minimally invasive plate osteosynthesis for osteofibrous dysplasia of the tibia: a case report. J Orthop Surg (Hong Kong). 2010;18(3):374–7.Google Scholar
  331. 331.
    Lee RS, Weitzel S, Eastwood DM, Monsell F, Pringle J, Cannon SR, Briggs TW. Osteofibrous dysplasia of the tibia. Is there a need for a radical surgical approach? J Bone Joint Surg Br. 2006;88(5):658–64.PubMedGoogle Scholar
  332. 332.
    Hahn SB, Kang ES, Jahng JS, Park BM, Choi JC. Ossifying fibroma. Yonsei Med J. 1991;32(4):347–55.PubMedGoogle Scholar
  333. 333.
    Ross JS, Masaryk TJ, Modic MT, Carter JR, Mapstone T, Dengel FH. Vertebral hemangiomas: MR imaging. Radiology. 1987;165(1):165–9.PubMedGoogle Scholar
  334. 334.
    Verbeke SLJ, Bovée JVMG. Review article: primary vascular tumors of bone: a spectrum of entities? Int J Clin Exp Pathol. 2011;4(6):541–51.PubMedPubMedCentralGoogle Scholar
  335. 335.
    Matsumoto K, Ishizawa M, Okabe H, Taniguchi I. Hemangioma of bone arising in the ulna: imaging findings with emphasis on MR. Skelet Radiol. 2000;29(4):231–4.Google Scholar
  336. 336.
    Wold LE, Adler CP, Sim FH, Unni KK. Atlas of orthopedic pathology. 2nd ed. Philadelphia: Saunders; 2002.Google Scholar
  337. 337.
    Rosai J, Gold J, Landy R. The histiocytoid hemangiomas. A unifying concept embracing several previously described entities of skin, soft tissue, large vessels, bone, and heart. Hum Pathol. 1979;10(6):707–30.PubMedGoogle Scholar
  338. 338.
    Errani C, Zhang L, Panicek DM, Healey JH, Antonescu CR. Epithelioid hemangioma of bone and soft tissue: a reappraisal of a controversial entity. Clin Orthop Relat Res. 2012;470(5):1498–506.PubMedGoogle Scholar
  339. 339.
    Nielsen GP, Srivastava A, Kattapuram S, Deshpande V, O’Connell JX, Mangham CD, Rosenberg AE. Epithelioid hemangioma of bone revisited: a study of 50 cases. Am J Surg Pathol. 2009;33(2):270–7.PubMedGoogle Scholar
  340. 340.
    Verbeke SL, Bovée JV. Primary vascular tumors of bone: a spectrum of entities? Int J Clin Exp Pathol. 2011;4(6):541–51.PubMedPubMedCentralGoogle Scholar
  341. 341.
    O’Connell JX, Kattapuram SV, Mankin HJ, Bhan AK, Rosenberg AE. Epithelioid hemangioma of bone. A tumor often mistaken for low-grade angiosarcoma or malignant hemangioendothelioma. Am J Surg Pathol. 1993;17(6):610–7.PubMedGoogle Scholar
  342. 342.
    Ling S, Rafii M, Klein M. Epithelioid hemangioma of bone. Skelet Radiol. 2001;30(4):226–9.Google Scholar
  343. 343.
    Kleer CG, Unni KK, McLeod RA. Epithelioid hemangioendothelioma of bone. Am J Surg Pathol. 1996;20(11):1301–11.PubMedGoogle Scholar
  344. 344.
    Gill R, O’Donnell RJ, Horvai A. Utility of immunohistochemistry for endothelial markers in distinguishing epithelioid hemangioendothelioma from carcinoma metastatic to bone. Arch Pathol Lab Med. 2009;133(6):967–72.PubMedGoogle Scholar
  345. 345.
    Kulkarni KR, Jambhekar NA. Epithelioid hemangioendothelioma of bone--a clinicopathologic and immunohistochemical study of 7 cases. Indian J Pathol Microbiol. 2003;46(4):600–4.PubMedGoogle Scholar
  346. 346.
    Errani C, Zhang L, Sung YS, Hajdu M, Singer S, Maki RG, Healey JH, Antonescu CR. A novel WWTR1-CAMTA1 gene fusion is a consistent abnormality in epithelioid hemangioendothelioma of different anatomic sites. Genes Chromosomes Cancer. 2011;50(8):644–53.PubMedPubMedCentralGoogle Scholar
  347. 347.
    Davies JD, Rees GJ, Mera SL. Angiosarcoma in irradiated post-mastectomy chest wall. Histopathology. 1983;7(6):947–56.PubMedGoogle Scholar
  348. 348.
    Antonescu C. Malignant vascular tumors – an update. Mod Pathol. 2014;27 Suppl 1:S30–8.PubMedGoogle Scholar
  349. 349.
    Campanacci M, Boriani S, Giunti A. Hemangioendothelioma of bone: a study of 29 cases. Cancer. 1980;46(4):804–14.PubMedGoogle Scholar
  350. 350.
    O’Connell JX, Nielsen GP, Rosenberg AE. Epithelioid vascular tumors of bone: a review and proposal of a classification scheme. Adv Anat Pathol. 2001;8(2):74–82.PubMedGoogle Scholar
  351. 351.
    Mittal S, Goswami C, Kanoria N, Bhattacharya A. Post-irradiation angiosarcoma of bone. J Cancer Res Ther. 2007;3(2):96–9.PubMedGoogle Scholar
  352. 352.
    Nakanishi K, Yoshikawa H, Ueda T, Araki N, Tanaka H, Aozasa K, Nakamura H. Postradiation sarcomas of the pelvis after treatment for uterine cervical cancer: review of the CT and MR findings of five cases. Skelet Radiol. 2001;30(3):132–7.Google Scholar
  353. 353.
    Wold LE, Unni KK, Beabout JW, Ivins JC, Bruckman JE, Dahlin DC. Hemangioendothelial sarcoma of bone. Am J Surg Pathol. 1982;6(1):59–70.PubMedGoogle Scholar
  354. 354.
    Verbeke SL, Bertoni F, Bacchini P, Sciot R, Fletcher CD, Kroon HM, Hogendoorn PC, Bovée JV. Distinct histological features characterize primary angiosarcoma of bone. Histopathology. 2011;58(2):254–64.PubMedGoogle Scholar
  355. 355.
    Volpe R, Mazabraud A. Hemangioendothelioma (angiosarcoma) of bone: a distinct pathologic entity with an unpredictable course? Cancer. 1982;49(4):727–36.PubMedGoogle Scholar
  356. 356.
    Deshpande V, Rosenberg AE, O’Connell JX, Nielsen GP. Epithelioid angiosarcoma of the bone: a series of 10 cases. Am J Surg Pathol. 2003;27(6):709–16.PubMedGoogle Scholar
  357. 357.
    Miettinen M, Lindenmayer AE, Chaubal A. Endothelial cell markers CD31, CD34, and BNH9 antibody to H- and Y-antigens – evaluation of their specificity and sensitivity in the diagnosis of vascular tumors and comparison with von Willebrand factor. Mod Pathol. 1994;7(1):82–90.PubMedGoogle Scholar
  358. 358.
    Dunlap JB, Magenis RE, Davis C, Himoe E, Mansoor A. Cytogenetic analysis of a primary bone angiosarcoma. Cancer Genet Cytogenet. 2009;194(1):1–3.PubMedGoogle Scholar
  359. 359.
    Manner J, Radlwimmer B, Hohenberger P, Mössinger K, Küffer S, Sauer C, Belharazem D, Zettl A, Coindre JM, Hallermann C, Hartmann JT, Katenkamp D, Katenkamp K, Schöffski P, Sciot R, Wozniak A, Lichter P, Marx A, Ströbel P. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol. 2010;176(1):34–9.PubMedPubMedCentralGoogle Scholar
  360. 360.
    Wenger DE, Wold LE. Malignant vascular lesions of bone: radiologic and pathologic features. Skelet Radiol. 2000;29(11):619–31. Review.Google Scholar
  361. 361.
    Palmerini E, Maki RG, Staals EL, Alberghini M, Antonescu CR, Ferrari C, Ruggieri P, Mavrogenis A, Bertoni F, Cesari M, Paioli A, Marchesi E, Picci P, Ferrari S. Primary angiosarcoma of bone: a retrospective analysis of 60 patients from 2 institutions. Am J Clin Oncol. 2014;37(6):528–34.PubMedPubMedCentralGoogle Scholar
  362. 362.
    Evans HL, Raymond AK, Ayala AG. Vascular tumors of bone: a study of 17 cases other than ordinary hemangioma, with an evaluation of the relationship of hemangioendothelioma of bone to epithelioid hemangioma, epithelioid hemangioendothelioma, and high-grade angiosarcoma. Hum Pathol. 2003;34(7):680–9.PubMedGoogle Scholar
  363. 363.
    Mirra JM, Brien EW. Giant notochordal hamartoma of intraosseous origin: a newly reported benign entity to be distinguished from chordoma. Report of two cases. Skelet Radiol. 2001;30(12):698–709. Epub 2001 Oct 16. Review. Erratum in: Skeletal Radiol 2002 Apr;31(4):251.Google Scholar
  364. 364.
    Yamaguchi T, Suzuki S, Ishiiwa H, Ueda Y. Intraosseous benign notochordal cell tumours: overlooked precursors of classic chordomas? Histopathology. 2004;44(6):597–602.PubMedGoogle Scholar
  365. 365.
    Kyriakos M, Totty WG, Lenke LG. Giant vertebral notochordal rest: a lesion distinct from chordoma: discussion of an evolving concept. Am J Surg Pathol. 2003;27(3):396–406. Review.PubMedGoogle Scholar
  366. 366.
    Deshpande V, Nielsen GP, Rosenthal DI, Rosenberg AE. Intraosseous benign notochord cell tumors (BNCT): further evidence supporting a relationship to chordoma. Am J Surg Pathol. 2007;31:1573–7.PubMedGoogle Scholar
  367. 367.
    Nishiguchi T, Mochizuki K, Tsujio T, Nishita T, Inoue Y. Lumbar vertebral chordoma arising from an intraosseous benign notochordal cell tumour: radiological findings and histopathological description with a good clinical outcome. Br J Radiol. 2010;83:e49–53.PubMedGoogle Scholar
  368. 368.
    Yamaguchi T, Yamato M, Saotome K. First histologically confirmed case of a classic chordoma arising in a precursor benign notochordallesion: differential diagnosis of benign and malignant notochordallesions. Skelet Radiol. 2002;31:413–8.Google Scholar
  369. 369.
    Yamaguchi T, Suzuki S, Ishiiwa H, Shimizu K, Ueda Y. Benign notochordal cell tumors: a comparative histological study of benign notochordal cell tumors, classic chordomas, and notochordal vestiges of fetal intervertebral discs. Am J Surg Pathol. 2004;28(6):756–61.PubMedGoogle Scholar
  370. 370.
    Yamaguchi T, Watanabe-Ishiiwa H, Suzuki S, Igarashi Y, Ueda Y. Incipient chordoma: a report of two cases of early-stage chordoma arising from benign notochordal cell tumors. Mod Pathol. 2005;18:1005–10.PubMedGoogle Scholar
  371. 371.
    Kyriakos M. Benign notochordal lesions of the axial skeleton: a review and current appraisal. Skelet Radiol. 2011;40(9):1141–52.  https://doi.org/10.1007/s00256-011-1167-6. Review.CrossRefGoogle Scholar
  372. 372.
    Dahlin DC, MacCarty CS. Chordoma. Cancer. 1952;5(6):1170–8.PubMedGoogle Scholar
  373. 373.
    Dahlin DC, Unni KK. Chordoma. Arch Pathol Lab Med. 1994;118(6):596–7.PubMedGoogle Scholar
  374. 374.
    Heffelfinger MJ, Dahlin DC, MacCarty CS, Beabout JW. Chordomas and cartilaginous tumors at the skull base. Cancer. 1973;32(2):410–20.PubMedGoogle Scholar
  375. 375.
    Forsyth PA, Cascino TL, Shaw EG, Scheithauer BW, O’Fallon JR, Dozier JC, Piepgras DG. Intracranial chordomas: a clinicopathological and prognostic study of 51 cases. J Neurosurg. 1993;78(5):741–7.PubMedGoogle Scholar
  376. 376.
    Brooks JJ, Trojanowski JQ, LiVolsi VA. Chondroid chordoma: a low-grade chondrosarcoma and its differential diagnosis. Curr Top Pathol. 1989;80:165–81.PubMedGoogle Scholar
  377. 377.
    Brooks JJ, LiVolsi VA, Trojanowski JQ. Does chondroid chordoma exist? Acta Neuropathol. 1987;72(3):229–35.PubMedGoogle Scholar
  378. 378.
    Meis JM, Raymond AK, Evans HL, Charles RE, Giraldo AA. “Dedifferentiated” chordoma. A clinicopathologic and immunohistochemical study of three cases. Am J Surg Pathol. 1987;11(7):516–25.PubMedGoogle Scholar
  379. 379.
    Smith J, Reuter V, Demas B. Case report 576. Anaplastic sacrococcygeal chordoma (dedifferentiated chordoma). Skelet Radiol. 1989;18(7):561–4. No abstract available.Google Scholar
  380. 380.
    Frankl J, Grotepas C, Stea B, Lemole GM, Chiu A, Khan R. Chordoma dedifferentiation after proton beam therapy: a case report and review of the literature. J Med Case Rep. 2016;10(1):280. Review.PubMedPubMedCentralGoogle Scholar
  381. 381.
    Fleming GF, Heimann PS, Stephens JK, Simon MA, Ferguson MK, Benjamin RS, Samuels BL. Dedifferentiated chordoma. Response to aggressive chemotherapy in two cases. Cancer. 1993;72(3):714–8. Review.PubMedGoogle Scholar
  382. 382.
    Zhou J, Sun J, Bai HX, Huang X, Zou Y, Tan X, Zhang Z, Tang X, Tao Y, Xiao B, Zhang PJ, Yang L. Prognostic factors in patients with spinal chordoma: an integrative analysis of 682 patients. Neurosurgery. 2017;81(5):812–23.PubMedGoogle Scholar
  383. 383.
    Chan AC, Tsang WY, Chan GP, Lam YL, Chan MK. Dedifferentiated chordoma with rhabdomyoblastic differentiation. Pathology. 2007;39(2):277–80. No abstract available.PubMedGoogle Scholar
  384. 384.
    Choi YJ, Kim TS. Malignant fibrous histiocytoma in chordoma – immunohistochemical evidence of transformation from chordoma to malignant fibrous histiocytoma. Yonsei Med J. 1994;35(2):239–43.PubMedGoogle Scholar
  385. 385.
    Chou WC, Hung YS, Lu CH, Yeh KY, Sheu S, Liaw CC. De novo dedifferentiated chordoma of the sacrum: a case report and review of the literature. Chang Gung Med J. 2009;32(3):330–5. Review.PubMedGoogle Scholar
  386. 386.
    Deepali J, Jain VK, Vassishta RK, Ranjan P, Kumar Y. Adamantinoma: a clinicopathological review and update. Diagn Pathol. 2008;3:8.Google Scholar
  387. 387.
    Baker PL, Dockerty MB, Coventry MB. Adamantinomas (so called) of long bones: review of literature and report of three new cases. J Bone Joint Surg. 1954;36A:704–20.Google Scholar
  388. 388.
    Weiss SW, Dorfman HD. Adamantinoma of long bone: an analysis of nine new cases with emphasis on metastasizing lesions and fibrous dysplasia–like changes. Hum Pathol. 1977;8:141–53.PubMedGoogle Scholar
  389. 389.
    Keeney GL, Unni KK, Beabout JW, Pritchard DJ. Adamantinoma of long bones. A clinicopathologic study of 85 cases. Cancer. 1989;64:730–7.PubMedGoogle Scholar
  390. 390.
    Huvos AG, Marcove RC. Adamantinoma of long bones. Clinicopathological study of fourteen cases with vascular origin suggested. J Bone Joint Surg Am. 1975;57(2):148–54.PubMedGoogle Scholar
  391. 391.
    Sarita-Reyes CD, Greco MA, Steiner GC. Mesenchymal-epithelial differentiation of adamantinoma of long bones: an immunohistochemical and ultrastructural study. Ultrastruct Pathol. 2012;36:23–30.PubMedGoogle Scholar
  392. 392.
    Benassi MS, Campanacci L, Gamberi G, Ferrari C, Picci P, Sangiorgi L, Campanacci M. Cytokeratin expression and distribution in adamantinoma of the long bones and osteofibrous dysplasia of tibia and fibula: an immunohistochemical study correlated to histogenesis. Histopathology. 1994;25:71–6.PubMedGoogle Scholar
  393. 393.
    Bridge JA, Fidler ME, Neff JR, Degenhardt J, Wang C, Dorfman HD, Baker KS, Seemayer TA. Adamantinoma-like Ewing’s sarcoma: genomic confirmation, phenotypic drift. Am J Surg Pathol. 1999;23(2):159–65.PubMedGoogle Scholar
  394. 394.
    Cohen DM, Dahlin DC, Pugh DG. Fibrous dysplasia associated with adamantinoma of the long bones. Cancer. 1962;15:515–21.PubMedGoogle Scholar
  395. 395.
    Eisenstein W, Pitcock JA. Adamantinoma of the tibia: an eccrine carcinoma. Arch Pathol Lab Med. 1984;108:246–50.PubMedGoogle Scholar
  396. 396.
    Hauben E, van den Broek, Van Marck E, Hogendoorn PC. Adamantinoma-like Ewing’s sarcoma and Ewing’s-like adamantinoma. The t(11;22), t(21;22) status. J Pathol. 2001;195(2):218–21.PubMedGoogle Scholar
  397. 397.
    Hazelbag HM, Laforga JB, Roels JH, Hogendoorn PC. Dedifferentiated adamantinoma with revertant mesenchymal phenotype. Am J Surg Pathol. 2003;27:1530–7.PubMedGoogle Scholar
  398. 398.
    Izquierdo FM, Ramos LR, Sanchez-Herraez S, Hernández T, de Alava E, Hazelbag HM. Dedifferentiated classic adamantinoma of the tibia: a report of a case with eventual complete revertant mesenchymal phenotype. Am J Surg Pathol. 2010;34:1388–92.PubMedGoogle Scholar
  399. 399.
    Kahn LB. Adamantinoma, osteofibrous dysplasia and differentiated adamantinoma. Skelet Radiol. 2003;32(5):245–58.Google Scholar
  400. 400.
    Kuruvilla G, Steiner GS. Osteofibrous dysplasia-like adamantinoma of bone: a report of five cases with immunohistochemical and ultrastructural studies. Hum Pathol. 1998;29(8):809–14.PubMedGoogle Scholar
  401. 401.
    Sung HW, Kuo DP, Shu WP, Chai YB, Liu CC, Li SM. Giant-cell tumor of bone: analysis of 208 cases in Chinese patients. J Bone Joint Surg. 1982;64A:755–61.Google Scholar
  402. 402.
    Bertoni F, Present D, Sudanese A, Baldini N, Bacchini P, Campanacci M. Giant-cell tumor of bone with pulmonary metastases: six case reports and a review of the literature. Clin Orthop. 1988;237:275–85.Google Scholar
  403. 403.
    Hoch B, Inwards C, Sundaram M, Rosenberg AE. Multicentric giant cell tumor of bone. Clinicopathologic analysis of thirty cases. J Bone Joint Surg Am. 2006;88:1998–2008.PubMedGoogle Scholar
  404. 404.
    Thomas D, Henshaw R, Skubitz K, Chawla S, Staddon A, Blay JY, Roudier M, Smith J, Ye Z, Sohn W, Dansey R, Jun S. Denosumab in patients with giant-cell tumour of bone: an open-label, phase 2 study. Lancet Oncol. 2010;11:275–80.PubMedGoogle Scholar
  405. 405.
    Roux S, Amazit L, Meduri G, Guiochon-Mantel A, Milgrom E, Mariette X. RANK (receptor activator of nuclear factor kappa B) and RANK ligand are expressed in giant cell tumors of bone. Am J Clin Pathol. 2002;117:210–6.PubMedGoogle Scholar
  406. 406.
    Jaffe HL, Lichtenstein L, Portis RB. Giant cell tumor of bone: its pathologic appearance, grading, supposed variants and treatment. Arch Pathol. 1940;30:993–1031.Google Scholar
  407. 407.
    Jaffe HL. Aneurysmal bone cyst. Bull Hosp Joint Dis. 1950;11(1):3–13.PubMedGoogle Scholar
  408. 408.
    Kransdorf MJ, Sweet DE. Aneurysmal bone cyst: concept, controversy, clinical presentation, and imaging. AJR Am J Roentgenol. 1995;164(3):573–80. Review.PubMedGoogle Scholar
  409. 409.
    Martinez V, Sissons HA. Aneurysmal bone cyst. A review of 123 cases including primary lesions and those secondary to other bone pathology. Cancer. 1988;61(11):2291–304.PubMedGoogle Scholar
  410. 410.
    Mankin HJ, Hornicek FJ, Ortiz-Cruz E, Villafuerte J, Gebhardt MC. Aneurysmal bone cyst: a review of 150 patients. J Clin Oncol. 2005;23(27):6756–62. Review.PubMedGoogle Scholar
  411. 411.
    Vergel De Dios AM, Bond JR, Shives TC, McLeod RA, Unni KK. Aneurysmal bone cyst. A clinicopathologic study of 238 cases. Cancer. 1992;69(12):2921–31.PubMedGoogle Scholar
  412. 412.
    Dahlin DC, McLeod RA. Aneurysmal bone cyst and other nonneoplastic conditions. Skelet Radiol. 1982;8(4):243–50.Google Scholar
  413. 413.
    Gipple JR, Pritchard DJ, Unni KK. Solid aneurysmal bone cyst. Orthopedics. 1992;15(12):1433–6.PubMedGoogle Scholar
  414. 414.
    Mascard E, Gomez-Brouchet A, Lambot K. Bone cysts: unicameral and aneurysmal bone cyst. Orthop Traumatol Surg Res. 2015;101(1 Suppl):S119–27.PubMedGoogle Scholar
  415. 415.
    Jaffe HL. Giant-cell reparative granuloma, traumatic bone cyst, and fibrous (fibro-osseous) dysplasia of the jaw bones. Oral Surg Oral Med Oral Pathol. 1953;6(1):159–75.PubMedGoogle Scholar
  416. 416.
    Lorenzo JC, Dorfman HD. Giant-cell reparative granuloma of short tubular bones of the hands and feet. Am J Surg Pathol. 1980;4(6):551–63.PubMedGoogle Scholar
  417. 417.
    Ilaslan H, Sundaram M, Unni KK. Solid variant of aneurysmal bone cysts in long tubular bones: giant cell reparative granuloma. AJR Am J Roentgenol. 2003;180(6):1681–7.PubMedGoogle Scholar
  418. 418.
    Bertoni F, Bacchini P, Capanna R, Ruggieri P, Biagini R, Ferruzzi A, Bettelli G, Picci P, Campanacci M. Solid variant of aneurysmal bone cyst. Cancer. 1993;71(3):729–34.PubMedGoogle Scholar
  419. 419.
    Agaram NP, LeLoarer FV, Zhang L, Hwang S, Athanasian EA, Hameed M, Antoescu CR. USP6 gene rearrangements occur preferentially in giant cell reparative granulomas of the hands and feet but not in gnathic location. Hum Pathol. 2014;45(6):1147–52.PubMedPubMedCentralGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • A. Kevin Raymond
    • 1
  1. 1.Department of PathologyThe University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations